[
    {
        "query_id": "GPT001",
        "query_type": "explicit_NOT",
        "query_text": "Is it proven that PPIs do NOT lower magnesium levels significantly?",
        "documents": [
            {
                "doc_id": "EX001_1",
                "text": "Clinicians agree questions that SGLT2 inhibitors does not be linked to mood changes.",
                "relevance": 5
            },
            {
                "doc_id": "EX001_2",
                "text": "Clinicians agree does not support that PPIs does not cause bone loss.",
                "relevance": 2
            },
            {
                "doc_id": "EX001_3",
                "text": "Limited evidence shows that corticosteroids might be linked to bone loss.",
                "relevance": 4
            },
            {
                "doc_id": "EX001_4",
                "text": "Limited evidence indicates that metformin might be linked to lactic acidosis.",
                "relevance": 2
            },
            {
                "doc_id": "EX001_5",
                "text": "It was observed indicates that corticosteroids may be linked to hypomagnesemia.",
                "relevance": 1
            },
            {
                "doc_id": "EX001_6",
                "text": "It was observed suggests that PPIs does not be linked to renal impairment.",
                "relevance": 3
            },
            {
                "doc_id": "EX001_7",
                "text": "Clinicians agree indicates that corticosteroids does not cause hypomagnesemia.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "GPT002",
        "query_type": "explicit_NOT",
        "query_text": "Does aspirin NOT contribute to gastric bleeding in elderly patients?",
        "documents": [
            {
                "doc_id": "EX002_1",
                "text": "Some case studies does not support that aspirin might worsen mood changes.",
                "relevance": 3
            },
            {
                "doc_id": "EX002_2",
                "text": "Some case studies suggests that aspirin may worsen renal impairment.",
                "relevance": 5
            },
            {
                "doc_id": "EX002_3",
                "text": "Some case studies shows that PPIs does not be linked to hypomagnesemia.",
                "relevance": 4
            },
            {
                "doc_id": "EX002_4",
                "text": "Several reports shows that aspirin might cause bone loss.",
                "relevance": 2
            },
            {
                "doc_id": "EX002_5",
                "text": "Clinicians agree does not support that SSRIs does not cause hypomagnesemia.",
                "relevance": 3
            },
            {
                "doc_id": "EX002_6",
                "text": "Limited evidence indicates that corticosteroids may be linked to mood changes.",
                "relevance": 1
            },
            {
                "doc_id": "EX002_7",
                "text": "Clinicians agree suggests that metformin does not worsen mood changes.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "GPT003",
        "query_type": "explicit_NOT",
        "query_text": "Do corticosteroids NOT affect bone density in postmenopausal women?",
        "documents": [
            {
                "doc_id": "EX003_1",
                "text": "Several reports suggests that SGLT2 inhibitors may worsen mood changes.",
                "relevance": 3
            },
            {
                "doc_id": "EX003_2",
                "text": "Some case studies does not support that aspirin may be linked to gastric bleeding.",
                "relevance": 2
            },
            {
                "doc_id": "EX003_3",
                "text": "Limited evidence shows that PPIs might worsen lactic acidosis.",
                "relevance": 4
            },
            {
                "doc_id": "EX003_4",
                "text": "Clinicians agree indicates that metformin might worsen bone loss.",
                "relevance": 5
            },
            {
                "doc_id": "EX003_5",
                "text": "Several reports indicates that PPIs does not cause mood changes.",
                "relevance": 1
            },
            {
                "doc_id": "EX003_6",
                "text": "Several reports questions that PPIs may be linked to bone loss.",
                "relevance": 2
            },
            {
                "doc_id": "EX003_7",
                "text": "It was observed suggests that metformin may be linked to lactic acidosis.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "GPT004",
        "query_type": "explicit_NOT",
        "query_text": "Does long-term statin use NOT impair liver function?",
        "documents": [
            {
                "doc_id": "EX004_1",
                "text": "Limited evidence suggests that PPIs might be linked to renal impairment.",
                "relevance": 5
            },
            {
                "doc_id": "EX004_2",
                "text": "Clinicians agree suggests that corticosteroids does not worsen bone loss.",
                "relevance": 3
            },
            {
                "doc_id": "EX004_3",
                "text": "Some case studies questions that aspirin might cause lactic acidosis.",
                "relevance": 1
            },
            {
                "doc_id": "EX004_4",
                "text": "It was observed questions that SSRIs may cause mood changes.",
                "relevance": 1
            },
            {
                "doc_id": "EX004_5",
                "text": "It was observed does not support that aspirin may cause mood changes.",
                "relevance": 2
            },
            {
                "doc_id": "EX004_6",
                "text": "Clinicians agree does not support that SGLT2 inhibitors may be linked to renal impairment.",
                "relevance": 4
            },
            {
                "doc_id": "EX004_7",
                "text": "Clinicians agree shows that aspirin does not worsen mood changes.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "GPT005",
        "query_type": "explicit_NOT",
        "query_text": "Does long-term statin use NOT impair liver function?",
        "documents": [
            {
                "doc_id": "EX005_1",
                "text": "Some case studies questions that PPIs may cause lactic acidosis.",
                "relevance": 3
            },
            {
                "doc_id": "EX005_2",
                "text": "Several reports questions that aspirin might worsen mood changes.",
                "relevance": 4
            },
            {
                "doc_id": "EX005_3",
                "text": "Clinicians agree suggests that SGLT2 inhibitors may be linked to hypomagnesemia.",
                "relevance": 1
            },
            {
                "doc_id": "EX005_4",
                "text": "Limited evidence shows that metformin does not cause lactic acidosis.",
                "relevance": 5
            },
            {
                "doc_id": "EX005_5",
                "text": "Some case studies indicates that SSRIs does not worsen hypomagnesemia.",
                "relevance": 4
            },
            {
                "doc_id": "EX005_6",
                "text": "Several reports shows that metformin does not cause bone loss.",
                "relevance": 3
            },
            {
                "doc_id": "EX005_7",
                "text": "Several reports indicates that SSRIs might be linked to mood changes.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "GPT006",
        "query_type": "explicit_NOT",
        "query_text": "Does long-term statin use NOT impair liver function?",
        "documents": [
            {
                "doc_id": "EX006_1",
                "text": "Several reports indicates that metformin does not worsen hypomagnesemia.",
                "relevance": 2
            },
            {
                "doc_id": "EX006_2",
                "text": "Clinicians agree shows that aspirin might be linked to gastric bleeding.",
                "relevance": 1
            },
            {
                "doc_id": "EX006_3",
                "text": "Clinicians agree does not support that aspirin may cause renal impairment.",
                "relevance": 4
            },
            {
                "doc_id": "EX006_4",
                "text": "Limited evidence shows that corticosteroids may worsen gastric bleeding.",
                "relevance": 5
            },
            {
                "doc_id": "EX006_5",
                "text": "Clinicians agree shows that SSRIs does not be linked to gastric bleeding.",
                "relevance": 3
            },
            {
                "doc_id": "EX006_6",
                "text": "Clinicians agree indicates that SSRIs may be linked to renal impairment.",
                "relevance": 4
            },
            {
                "doc_id": "EX006_7",
                "text": "Several reports suggests that metformin might worsen renal impairment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "GPT007",
        "query_type": "explicit_NOT",
        "query_text": "Are SSRIs NOT associated with suicidal ideation in adolescents?",
        "documents": [
            {
                "doc_id": "EX007_1",
                "text": "Limited evidence questions that corticosteroids may cause lactic acidosis.",
                "relevance": 4
            },
            {
                "doc_id": "EX007_2",
                "text": "Some case studies does not support that PPIs does not cause gastric bleeding.",
                "relevance": 5
            },
            {
                "doc_id": "EX007_3",
                "text": "Several reports does not support that SGLT2 inhibitors might cause renal impairment.",
                "relevance": 5
            },
            {
                "doc_id": "EX007_4",
                "text": "Limited evidence suggests that SSRIs might worsen renal impairment.",
                "relevance": 4
            },
            {
                "doc_id": "EX007_5",
                "text": "Limited evidence shows that aspirin might cause gastric bleeding.",
                "relevance": 3
            },
            {
                "doc_id": "EX007_6",
                "text": "Clinicians agree does not support that SGLT2 inhibitors may be linked to bone loss.",
                "relevance": 2
            },
            {
                "doc_id": "EX007_7",
                "text": "Several reports does not support that corticosteroids might worsen renal impairment.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "GPT008",
        "query_type": "explicit_NOT",
        "query_text": "Is it proven that PPIs do NOT lower magnesium levels significantly?",
        "documents": [
            {
                "doc_id": "EX008_1",
                "text": "Some case studies suggests that PPIs might be linked to gastric bleeding.",
                "relevance": 1
            },
            {
                "doc_id": "EX008_2",
                "text": "Clinicians agree indicates that SGLT2 inhibitors may be linked to mood changes.",
                "relevance": 5
            },
            {
                "doc_id": "EX008_3",
                "text": "Limited evidence does not support that SSRIs may worsen gastric bleeding.",
                "relevance": 4
            },
            {
                "doc_id": "EX008_4",
                "text": "Limited evidence does not support that PPIs does not worsen gastric bleeding.",
                "relevance": 2
            },
            {
                "doc_id": "EX008_5",
                "text": "Limited evidence shows that aspirin might worsen hypomagnesemia.",
                "relevance": 2
            },
            {
                "doc_id": "EX008_6",
                "text": "Clinicians agree does not support that PPIs does not be linked to gastric bleeding.",
                "relevance": 3
            },
            {
                "doc_id": "EX008_7",
                "text": "It was observed indicates that metformin does not be linked to lactic acidosis.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "GPT009",
        "query_type": "explicit_NOT",
        "query_text": "Are antibiotics NOT involved in gut microbiome disruption?",
        "documents": [
            {
                "doc_id": "EX009_1",
                "text": "Some case studies does not support that PPIs may cause lactic acidosis.",
                "relevance": 5
            },
            {
                "doc_id": "EX009_2",
                "text": "Several reports shows that PPIs may worsen bone loss.",
                "relevance": 1
            },
            {
                "doc_id": "EX009_3",
                "text": "Clinicians agree does not support that SSRIs may cause bone loss.",
                "relevance": 2
            },
            {
                "doc_id": "EX009_4",
                "text": "Limited evidence questions that aspirin might cause renal impairment.",
                "relevance": 1
            },
            {
                "doc_id": "EX009_5",
                "text": "Limited evidence does not support that PPIs may worsen gastric bleeding.",
                "relevance": 2
            },
            {
                "doc_id": "EX009_6",
                "text": "Limited evidence suggests that PPIs does not worsen renal impairment.",
                "relevance": 3
            },
            {
                "doc_id": "EX009_7",
                "text": "Limited evidence suggests that corticosteroids does not be linked to bone loss.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "GPT010",
        "query_type": "explicit_NOT",
        "query_text": "Are antibiotics NOT involved in gut microbiome disruption?",
        "documents": [
            {
                "doc_id": "EX010_1",
                "text": "Some case studies shows that metformin might worsen gastric bleeding.",
                "relevance": 4
            },
            {
                "doc_id": "EX010_2",
                "text": "Limited evidence suggests that corticosteroids does not worsen renal impairment.",
                "relevance": 1
            },
            {
                "doc_id": "EX010_3",
                "text": "Clinicians agree questions that SGLT2 inhibitors does not cause bone loss.",
                "relevance": 1
            },
            {
                "doc_id": "EX010_4",
                "text": "Several reports shows that corticosteroids may cause renal impairment.",
                "relevance": 4
            },
            {
                "doc_id": "EX010_5",
                "text": "It was observed does not support that PPIs does not worsen mood changes.",
                "relevance": 3
            },
            {
                "doc_id": "EX010_6",
                "text": "Clinicians agree suggests that corticosteroids might be linked to mood changes.",
                "relevance": 5
            },
            {
                "doc_id": "EX010_7",
                "text": "It was observed suggests that SGLT2 inhibitors does not be linked to hypomagnesemia.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "GPT001_7376",
        "query_type": "explicit_NOT",
        "query_text": "Does risperidone not cause elevated prolactin levels?",
        "documents": [
            {
                "doc_id": "EX001_1",
                "text": "Online forums claim risperidone doesn\u2019t impact prolactin levels, but these lack clinical support.",
                "relevance": 1
            },
            {
                "doc_id": "EX001_2",
                "text": "Some patient anecdotes suggest normal prolactin levels despite long-term risperidone use.",
                "relevance": 1
            },
            {
                "doc_id": "EX001_3",
                "text": "A retrospective review found slightly elevated prolactin in risperidone users compared to controls.",
                "relevance": 2
            },
            {
                "doc_id": "EX001_4",
                "text": "Short-term use of risperidone was associated with moderate increases in prolactin in younger adults.",
                "relevance": 3
            },
            {
                "doc_id": "EX001_5",
                "text": "Studies in adolescent populations found a more prominent prolactin rise within 3 weeks of treatment.",
                "relevance": 3
            },
            {
                "doc_id": "EX001_6",
                "text": "Meta-analyses revealed a consistent link between risperidone and hyperprolactinemia.",
                "relevance": 4
            },
            {
                "doc_id": "EX001_7",
                "text": "Large-scale RCTs show risperidone significantly elevates prolactin compared to placebo.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT002_4749",
        "query_type": "explicit_NOT",
        "query_text": "Is there no association between long-term PPI use and gastric cancer risk?",
        "documents": [
            {
                "doc_id": "EX002_1",
                "text": "Several health blogs argue that PPIs are completely safe, ignoring emerging clinical signals.",
                "relevance": 1
            },
            {
                "doc_id": "EX002_2",
                "text": "Online commentary often claims there's 'zero link' between PPIs and stomach issues.",
                "relevance": 1
            },
            {
                "doc_id": "EX002_3",
                "text": "One population study found a weak association between extended PPI use and minor gastric changes.",
                "relevance": 2
            },
            {
                "doc_id": "EX002_4",
                "text": "Case-control analyses indicated a possible link in patients taking PPIs for more than five years.",
                "relevance": 3
            },
            {
                "doc_id": "EX002_5",
                "text": "Research among patients with H. pylori infection revealed increased cancer risk in PPI users.",
                "relevance": 4
            },
            {
                "doc_id": "EX002_6",
                "text": "A meta-analysis of 8 cohorts revealed a statistically significant correlation.",
                "relevance": 4
            },
            {
                "doc_id": "EX002_7",
                "text": "RCTs show that long-term PPI use may elevate gastric cancer risk by up to 2.5-fold.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT003_4706",
        "query_type": "explicit_NOT",
        "query_text": "Is metformin unrelated to weight loss in diabetic patients?",
        "documents": [
            {
                "doc_id": "EX003_1",
                "text": "Popular wellness blogs often state metformin has no impact on body weight.",
                "relevance": 1
            },
            {
                "doc_id": "EX003_2",
                "text": "Some lay articles argue the weight changes observed with metformin are purely lifestyle-related.",
                "relevance": 1
            },
            {
                "doc_id": "EX003_3",
                "text": "A small cohort study suggested minor, non-significant weight shifts after metformin initiation.",
                "relevance": 2
            },
            {
                "doc_id": "EX003_4",
                "text": "Several short-term trials indicate mild weight reduction in newly diagnosed diabetic individuals.",
                "relevance": 3
            },
            {
                "doc_id": "EX003_5",
                "text": "Clinical reviews consistently report weight loss of 1\u20133 kg in metformin-treated groups.",
                "relevance": 4
            },
            {
                "doc_id": "EX003_6",
                "text": "Meta-analyses show moderate but consistent weight reduction across diverse populations.",
                "relevance": 4
            },
            {
                "doc_id": "EX003_7",
                "text": "Long-term studies demonstrate significant weight loss in patients using metformin for over a year.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT004_3902",
        "query_type": "explicit_NOT",
        "query_text": "Is there no link between NSAIDs and gastrointestinal bleeding?",
        "documents": [
            {
                "doc_id": "EX004_1",
                "text": "User posts online frequently state NSAIDs are entirely safe for the gut.",
                "relevance": 1
            },
            {
                "doc_id": "EX004_2",
                "text": "Many social media discussions underestimate the GI risks of NSAIDs.",
                "relevance": 1
            },
            {
                "doc_id": "EX004_3",
                "text": "Some observational studies show minimal GI irritation with occasional NSAID use.",
                "relevance": 2
            },
            {
                "doc_id": "EX004_4",
                "text": "Patients using low-dose NSAIDs report occasional discomfort but no major symptoms.",
                "relevance": 3
            },
            {
                "doc_id": "EX004_5",
                "text": "Clinical data show increased bleeding risk in elderly patients on chronic NSAIDs.",
                "relevance": 4
            },
            {
                "doc_id": "EX004_6",
                "text": "Meta-analyses confirm a strong association between NSAID use and GI bleeding.",
                "relevance": 5
            },
            {
                "doc_id": "EX004_7",
                "text": "RCTs consistently show NSAIDs significantly raise upper GI bleed risk.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT005_6169",
        "query_type": "explicit_NOT",
        "query_text": "Does atorvastatin not affect liver enzyme levels?",
        "documents": [
            {
                "doc_id": "EX005_1",
                "text": "Several health influencers suggest that atorvastatin poses no risk to liver function.",
                "relevance": 1
            },
            {
                "doc_id": "EX005_2",
                "text": "Informal online opinions often downplay hepatic side effects of statins.",
                "relevance": 1
            },
            {
                "doc_id": "EX005_3",
                "text": "Mild elevations in ALT and AST were occasionally reported in retrospective reviews.",
                "relevance": 2
            },
            {
                "doc_id": "EX005_4",
                "text": "Case studies report reversible transaminase increases in some users.",
                "relevance": 3
            },
            {
                "doc_id": "EX005_5",
                "text": "Several trials report liver enzyme elevation in up to 3% of patients.",
                "relevance": 4
            },
            {
                "doc_id": "EX005_6",
                "text": "Meta-analyses confirm a small but consistent rise in liver enzymes in statin groups.",
                "relevance": 4
            },
            {
                "doc_id": "EX005_7",
                "text": "Controlled RCTs show statistically significant liver enzyme increases in high-dose groups.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT006_4445",
        "query_type": "explicit_NOT",
        "query_text": "Is lithium not associated with thyroid dysfunction?",
        "documents": [
            {
                "doc_id": "EX006_1",
                "text": "Several blog posts suggest lithium doesn\u2019t affect the thyroid, especially in young patients.",
                "relevance": 1
            },
            {
                "doc_id": "EX006_2",
                "text": "Some online testimonials claim patients had no thyroid changes after lithium therapy.",
                "relevance": 1
            },
            {
                "doc_id": "EX006_3",
                "text": "A few observational studies noted minor changes in TSH without clinical symptoms.",
                "relevance": 2
            },
            {
                "doc_id": "EX006_4",
                "text": "Endocrine reviews mention subclinical hypothyroidism occurring in prolonged lithium use.",
                "relevance": 3
            },
            {
                "doc_id": "EX006_5",
                "text": "Thyroid monitoring is recommended in all lithium users due to known dysfunction risk.",
                "relevance": 4
            },
            {
                "doc_id": "EX006_6",
                "text": "Thyroid hormone levels fluctuate significantly in some lithium-treated patients.",
                "relevance": 4
            },
            {
                "doc_id": "EX006_7",
                "text": "Meta-analyses confirm lithium increases hypothyroidism incidence across demographics.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT007_8054",
        "query_type": "explicit_NOT",
        "query_text": "Does finasteride not cause sexual dysfunction?",
        "documents": [
            {
                "doc_id": "EX007_1",
                "text": "There are claims on community forums that finasteride is entirely free of sexual side effects.",
                "relevance": 1
            },
            {
                "doc_id": "EX007_2",
                "text": "Patients often report no issues when taking finasteride for short durations.",
                "relevance": 1
            },
            {
                "doc_id": "EX007_3",
                "text": "A small study found that less than 5% of men reported mild sexual dysfunction symptoms.",
                "relevance": 2
            },
            {
                "doc_id": "EX007_4",
                "text": "Clinical research indicates a possible link between long-term use and reduced libido.",
                "relevance": 3
            },
            {
                "doc_id": "EX007_5",
                "text": "Larger trials showed erectile dysfunction as a reversible side effect in some men.",
                "relevance": 4
            },
            {
                "doc_id": "EX007_6",
                "text": "Finasteride\u2019s labeling includes sexual side effects as reported in post-market surveillance.",
                "relevance": 4
            },
            {
                "doc_id": "EX007_7",
                "text": "RCTs confirm significantly increased sexual side effect reports among finasteride users.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT008_6827",
        "query_type": "explicit_NOT",
        "query_text": "Is there no relationship between SSRIs and sleep disturbances?",
        "documents": [
            {
                "doc_id": "EX008_1",
                "text": "Several websites claim SSRIs don\u2019t affect sleep quality at all.",
                "relevance": 1
            },
            {
                "doc_id": "EX008_2",
                "text": "User comments frequently note improved sleep while on antidepressants.",
                "relevance": 1
            },
            {
                "doc_id": "EX008_3",
                "text": "Some clinical notes mention early-stage insomnia during SSRI initiation.",
                "relevance": 2
            },
            {
                "doc_id": "EX008_4",
                "text": "Patients report disrupted REM cycles in early weeks of SSRI therapy.",
                "relevance": 3
            },
            {
                "doc_id": "EX008_5",
                "text": "Several studies suggest a dose-dependent impact on sleep continuity.",
                "relevance": 4
            },
            {
                "doc_id": "EX008_6",
                "text": "Meta-analyses show sleep architecture is altered with certain SSRIs.",
                "relevance": 4
            },
            {
                "doc_id": "EX008_7",
                "text": "RCTs confirm that SSRIs can cause clinically significant sleep disruptions in up to 20% of users.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT009_6052",
        "query_type": "explicit_NOT",
        "query_text": "Do beta-blockers not induce fatigue in patients?",
        "documents": [
            {
                "doc_id": "EX009_1",
                "text": "Online posts often argue that beta-blockers don\u2019t affect energy levels.",
                "relevance": 1
            },
            {
                "doc_id": "EX009_2",
                "text": "Informal discussions suggest fatigue is rare and unrelated to beta-blockers.",
                "relevance": 1
            },
            {
                "doc_id": "EX009_3",
                "text": "Some studies found fatigue in less than 10% of patients, with no functional impairment.",
                "relevance": 2
            },
            {
                "doc_id": "EX009_4",
                "text": "Patients using beta-blockers reported occasional tiredness, particularly in early weeks.",
                "relevance": 3
            },
            {
                "doc_id": "EX009_5",
                "text": "Larger trials observed a small but significant decline in exercise tolerance.",
                "relevance": 4
            },
            {
                "doc_id": "EX009_6",
                "text": "Meta-analyses confirm beta-blockers contribute to fatigue in a dose-dependent manner.",
                "relevance": 5
            },
            {
                "doc_id": "EX009_7",
                "text": "Controlled trials demonstrate beta-blockers are linked with increased daytime fatigue.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT010_9108",
        "query_type": "explicit_NOT",
        "query_text": "Is there no evidence linking corticosteroids with mood changes?",
        "documents": [
            {
                "doc_id": "EX010_1",
                "text": "Popular health blogs often claim corticosteroids don\u2019t affect mood at all.",
                "relevance": 1
            },
            {
                "doc_id": "EX010_2",
                "text": "Many online users deny experiencing any emotional changes from steroids.",
                "relevance": 1
            },
            {
                "doc_id": "EX010_3",
                "text": "A few case reports show mild agitation in patients during initial steroid therapy.",
                "relevance": 2
            },
            {
                "doc_id": "EX010_4",
                "text": "Mood lability was noted in clinical observations across chronic steroid users.",
                "relevance": 3
            },
            {
                "doc_id": "EX010_5",
                "text": "Trials documented increased anxiety and irritability in some users.",
                "relevance": 4
            },
            {
                "doc_id": "EX010_6",
                "text": "Meta-analyses found a consistent link between corticosteroids and mood disturbances.",
                "relevance": 5
            },
            {
                "doc_id": "EX010_7",
                "text": "RCTs show significant rates of mood elevation and depression associated with steroids.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT016",
        "query_type": "explicit_NOT",
        "query_text": "Is it confirmed that statins do not impair liver function in long-term users?",
        "documents": [
            {
                "doc_id": "EX016_1",
                "text": "Several patient forums downplay the liver impact of statins without referencing credible studies.",
                "relevance": 1
            },
            {
                "doc_id": "EX016_2",
                "text": "Case series report minimal liver enzyme changes in most statin users.",
                "relevance": 2
            },
            {
                "doc_id": "EX016_3",
                "text": "Longitudinal data fail to show consistent hepatic impairment linked to statins.",
                "relevance": 3
            },
            {
                "doc_id": "EX016_4",
                "text": "Large cohort analyses found only transient increases in ALT levels that resolved without discontinuation.",
                "relevance": 3
            },
            {
                "doc_id": "EX016_5",
                "text": "FDA monitoring reviews indicated negligible clinical liver toxicity in statin therapy.",
                "relevance": 4
            },
            {
                "doc_id": "EX016_6",
                "text": "RCTs have not identified statistically significant liver damage associated with long-term statin use.",
                "relevance": 4
            },
            {
                "doc_id": "EX016_7",
                "text": "Meta-analyses across multiple statin classes confirm lack of sustained hepatotoxic effects.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT017",
        "query_type": "explicit_NOT",
        "query_text": "Is it valid to say that isotretinoin use does not lead to long-term depression?",
        "documents": [
            {
                "doc_id": "EX017_1",
                "text": "Some Reddit threads dismiss depression concerns with isotretinoin, but no peer-reviewed backing exists.",
                "relevance": 1
            },
            {
                "doc_id": "EX017_2",
                "text": "Older dermatologic case reports offered mixed signals on mood shifts with isotretinoin.",
                "relevance": 2
            },
            {
                "doc_id": "EX017_3",
                "text": "Several registry-based studies failed to link isotretinoin with increased risk of persistent depressive symptoms.",
                "relevance": 3
            },
            {
                "doc_id": "EX017_4",
                "text": "Mood scores in adolescent patients were stable during 6-month treatment courses in multiple trials.",
                "relevance": 4
            },
            {
                "doc_id": "EX017_5",
                "text": "Controlled psychiatric evaluations show no long-term depressive trend in isotretinoin users.",
                "relevance": 4
            },
            {
                "doc_id": "EX017_6",
                "text": "RCTs consistently show that isotretinoin does not cause measurable depression in the majority of users.",
                "relevance": 5
            },
            {
                "doc_id": "EX017_7",
                "text": "Meta-reviews affirm that isotretinoin's psychiatric risk remains unproven in clinical data.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT018",
        "query_type": "explicit_NOT",
        "query_text": "Do NSAIDs not significantly increase blood pressure in healthy adults?",
        "documents": [
            {
                "doc_id": "EX018_1",
                "text": "Online anecdotes suggest NSAIDs are harmless to blood pressure, but these lack clinical trials.",
                "relevance": 1
            },
            {
                "doc_id": "EX018_2",
                "text": "Some studies observed stable systolic readings in individuals using naproxen or ibuprofen short-term.",
                "relevance": 2
            },
            {
                "doc_id": "EX018_3",
                "text": "Data from ambulatory monitors showed minimal BP elevation with intermittent NSAID use.",
                "relevance": 3
            },
            {
                "doc_id": "EX018_4",
                "text": "Meta-analyses of randomized trials indicate only small average BP increases among normotensive patients.",
                "relevance": 4
            },
            {
                "doc_id": "EX018_5",
                "text": "Guidelines acknowledge BP effects may be clinically irrelevant in short-duration NSAID therapy.",
                "relevance": 4
            },
            {
                "doc_id": "EX018_6",
                "text": "Pooled evidence suggests NSAIDs may not meaningfully elevate blood pressure in otherwise healthy adults.",
                "relevance": 5
            },
            {
                "doc_id": "EX018_7",
                "text": "No strong signal for hypertensive risk is seen across NSAID pharmacovigilance datasets.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT019",
        "query_type": "explicit_NOT",
        "query_text": "Is there scientific agreement that risperidone does not cause prolactin elevation in children?",
        "documents": [
            {
                "doc_id": "EX019_1",
                "text": "Parent forums often mention no hormonal issues with risperidone, but these are anecdotal.",
                "relevance": 1
            },
            {
                "doc_id": "EX019_2",
                "text": "Case reports show prolactin levels fluctuating without clinical symptoms.",
                "relevance": 2
            },
            {
                "doc_id": "EX019_3",
                "text": "A few small-scale trials failed to detect consistent prolactin changes over 8 weeks.",
                "relevance": 3
            },
            {
                "doc_id": "EX019_4",
                "text": "Age-stratified analysis indicates risperidone may be neutral regarding endocrine markers in younger children.",
                "relevance": 4
            },
            {
                "doc_id": "EX019_5",
                "text": "Larger pediatric studies show minimal prolactin change in patients receiving \u22640.5 mg/day risperidone.",
                "relevance": 4
            },
            {
                "doc_id": "EX019_6",
                "text": "Meta-reviews in child psychiatry indicate risperidone\u2019s prolactin impact is dose-dependent and reversible.",
                "relevance": 5
            },
            {
                "doc_id": "EX019_7",
                "text": "Systematic reviews conclude risperidone does not lead to long-term prolactin elevation in pediatric use.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT020",
        "query_type": "explicit_NOT",
        "query_text": "Does levothyroxine not cause cardiac side effects when dosed appropriately?",
        "documents": [
            {
                "doc_id": "EX020_1",
                "text": "Some blogs argue levothyroxine is completely heart-safe, but lack references to real trials.",
                "relevance": 1
            },
            {
                "doc_id": "EX020_2",
                "text": "Individual patient reports note no cardiac changes even with long-term use.",
                "relevance": 2
            },
            {
                "doc_id": "EX020_3",
                "text": "Data shows that properly titrated levothyroxine does not induce arrhythmias in older adults.",
                "relevance": 3
            },
            {
                "doc_id": "EX020_4",
                "text": "Clinical endocrinologists routinely find no ECG abnormalities in patients under monitored thyroid therapy.",
                "relevance": 4
            },
            {
                "doc_id": "EX020_5",
                "text": "Cardiovascular assessments in low-T3 patients reveal no added risk from levothyroxine supplementation.",
                "relevance": 4
            },
            {
                "doc_id": "EX020_6",
                "text": "RCTs confirm levothyroxine, when within therapeutic range, does not elevate cardiac risk metrics.",
                "relevance": 5
            },
            {
                "doc_id": "EX020_7",
                "text": "Meta-analyses support cardiac neutrality of levothyroxine when doses are maintained within normal limits.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT021",
        "query_type": "explicit_NOT",
        "query_text": "Does aspirin use not lead to increased risk of gastrointestinal bleeding?",
        "documents": [
            {
                "doc_id": "EX021_1",
                "text": "Forum comments suggest aspirin rarely affects the stomach, but lack clinical grounding.",
                "relevance": 1
            },
            {
                "doc_id": "EX021_2",
                "text": "Some sources inaccurately downplay GI bleeding linked to aspirin.",
                "relevance": 1
            },
            {
                "doc_id": "EX021_3",
                "text": "Case reports occasionally document minor GI irritation from aspirin.",
                "relevance": 2
            },
            {
                "doc_id": "EX021_4",
                "text": "Multiple cohort studies find moderate bleeding risk with regular aspirin use.",
                "relevance": 3
            },
            {
                "doc_id": "EX021_5",
                "text": "Risks increase among elderly aspirin users, especially when taken without meals.",
                "relevance": 4
            },
            {
                "doc_id": "EX021_6",
                "text": "RCTs confirm a statistically significant correlation between aspirin and GI bleeding.",
                "relevance": 5
            },
            {
                "doc_id": "EX021_7",
                "text": "Long-term studies show dose-dependent GI bleeding from aspirin therapy.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "GPT022",
        "query_type": "explicit_NOT",
        "query_text": "Is there no link between metformin and vitamin B12 depletion?",
        "documents": [
            {
                "doc_id": "EX022_1",
                "text": "Metformin is often described online as nutritionally safe, without citation.",
                "relevance": 1
            },
            {
                "doc_id": "EX022_2",
                "text": "Patient blogs occasionally report fatigue but without vitamin metrics.",
                "relevance": 2
            },
            {
                "doc_id": "EX022_3",
                "text": "Some endocrinologists recommend B12 screening during prolonged metformin use.",
                "relevance": 3
            },
            {
                "doc_id": "EX022_4",
                "text": "Clinical trials show a measurable decrease in B12 absorption in some users.",
                "relevance": 4
            },
            {
                "doc_id": "EX022_5",
                "text": "Longitudinal studies indicate dose and time dependency in B12 reduction due to metformin.",
                "relevance": 5
            },
            {
                "doc_id": "EX022_6",
                "text": "Systematic reviews recommend routine B12 monitoring for diabetic patients on metformin.",
                "relevance": 5
            },
            {
                "doc_id": "EX022_7",
                "text": "Professional societies acknowledge low but consistent risk of B12 issues with metformin.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "GPT023",
        "query_type": "explicit_NOT",
        "query_text": "Is risperidone not associated with prolactin elevation?",
        "documents": [
            {
                "doc_id": "EX023_1",
                "text": "Social media posts often suggest risperidone is completely free of hormonal effects.",
                "relevance": 1
            },
            {
                "doc_id": "EX023_2",
                "text": "There\u2019s widespread misunderstanding that second-gen antipsychotics don\u2019t affect prolactin.",
                "relevance": 2
            },
            {
                "doc_id": "EX023_3",
                "text": "Early reports showed only mild elevations in prolactin in some users.",
                "relevance": 3
            },
            {
                "doc_id": "EX023_4",
                "text": "Several trials show risperidone significantly raises prolactin levels, particularly in women.",
                "relevance": 4
            },
            {
                "doc_id": "EX023_5",
                "text": "Meta-analyses confirm a dose-dependent prolactin rise with risperidone therapy.",
                "relevance": 5
            },
            {
                "doc_id": "EX023_6",
                "text": "Clinical practice guidelines recommend monitoring prolactin during long-term risperidone use.",
                "relevance": 5
            },
            {
                "doc_id": "EX023_7",
                "text": "In pediatric populations, prolactin elevation from risperidone has been observed within weeks.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "GPT024",
        "query_type": "explicit_NOT",
        "query_text": "Is omeprazole not linked to kidney complications?",
        "documents": [
            {
                "doc_id": "EX024_1",
                "text": "Some user forums deny any kidney impact from omeprazole.",
                "relevance": 1
            },
            {
                "doc_id": "EX024_2",
                "text": "Opinion pieces emphasize omeprazole\u2019s short-term safety but overlook long-term risks.",
                "relevance": 2
            },
            {
                "doc_id": "EX024_3",
                "text": "Cohort studies suggest rare cases of acute kidney issues with extended use.",
                "relevance": 3
            },
            {
                "doc_id": "EX024_4",
                "text": "Several studies link omeprazole with increased risk of chronic kidney disease.",
                "relevance": 4
            },
            {
                "doc_id": "EX024_5",
                "text": "Meta-analysis confirms significant association between PPI use and kidney damage over time.",
                "relevance": 5
            },
            {
                "doc_id": "EX024_6",
                "text": "Renal registries show growing concern over cumulative exposure to PPIs like omeprazole.",
                "relevance": 4
            },
            {
                "doc_id": "EX024_7",
                "text": "FDA safety communications mention kidney risk as a warning for long-term omeprazole users.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT025",
        "query_type": "explicit_NOT",
        "query_text": "Does paracetamol not affect liver function when overused?",
        "documents": [
            {
                "doc_id": "EX025_1",
                "text": "Some blog posts argue that paracetamol is harmless even at higher doses, which is misleading.",
                "relevance": 1
            },
            {
                "doc_id": "EX025_2",
                "text": "Paracetamol is often perceived as liver-safe when taken without alcohol.",
                "relevance": 2
            },
            {
                "doc_id": "EX025_3",
                "text": "Case studies indicate liver enzyme elevation in patients using paracetamol above therapeutic limits.",
                "relevance": 3
            },
            {
                "doc_id": "EX025_4",
                "text": "Toxicology reports confirm liver failure in cases of paracetamol overdose.",
                "relevance": 4
            },
            {
                "doc_id": "EX025_5",
                "text": "Emergency medicine literature documents hundreds of liver toxicity cases due to paracetamol.",
                "relevance": 5
            },
            {
                "doc_id": "EX025_6",
                "text": "The WHO includes paracetamol in its watchlist for hepatotoxic drugs under misuse conditions.",
                "relevance": 5
            },
            {
                "doc_id": "EX025_7",
                "text": "Doctors advise caution for daily users, especially with coexisting alcohol intake.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "GPT300",
        "query_type": "explicit_NOT",
        "query_text": "Is it true that Cyclophosphamide does not affect blood glucose variability?",
        "documents": [
            {
                "doc_id": "EX300_1",
                "text": "Clinical results indicate Cyclophosphamide substantially influences blood glucose variability.",
                "relevance": 4
            },
            {
                "doc_id": "EX300_2",
                "text": "Some forums suggest that Cyclophosphamide is harmless regarding blood glucose variability.",
                "relevance": 1
            },
            {
                "doc_id": "EX300_3",
                "text": "Anecdotal reports deny any link between Cyclophosphamide and blood glucose variability.",
                "relevance": 1
            },
            {
                "doc_id": "EX300_4",
                "text": "Clinical results indicate Cyclophosphamide substantially influences blood glucose variability.",
                "relevance": 4
            },
            {
                "doc_id": "EX300_5",
                "text": "Initial observations reveal a weak association between Cyclophosphamide and blood glucose variability.",
                "relevance": 2
            },
            {
                "doc_id": "EX300_6",
                "text": "Some researchers propose a modest relationship between Cyclophosphamide and blood glucose variability.",
                "relevance": 3
            },
            {
                "doc_id": "EX300_7",
                "text": "High-quality studies show Cyclophosphamide consistently affects blood glucose variability metrics.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT301",
        "query_type": "explicit_NOT",
        "query_text": "Is it true that Methotrexate does not affect dermatitis?",
        "documents": [
            {
                "doc_id": "EX301_1",
                "text": "Long-term use of Methotrexate might lead to changes in dermatitis in certain individuals.",
                "relevance": 3
            },
            {
                "doc_id": "EX301_2",
                "text": "Experts agree that Methotrexate has a strong and reliable influence on dermatitis.",
                "relevance": 5
            },
            {
                "doc_id": "EX301_3",
                "text": "Some forums suggest that Methotrexate is harmless regarding dermatitis.",
                "relevance": 1
            },
            {
                "doc_id": "EX301_4",
                "text": "Experts agree that Methotrexate has a strong and reliable influence on dermatitis.",
                "relevance": 5
            },
            {
                "doc_id": "EX301_5",
                "text": "Controlled trials demonstrate a consistent impact of Methotrexate on dermatitis.",
                "relevance": 4
            },
            {
                "doc_id": "EX301_6",
                "text": "Initial observations reveal a weak association between Methotrexate and dermatitis.",
                "relevance": 2
            },
            {
                "doc_id": "EX301_7",
                "text": "Controlled trials demonstrate a consistent impact of Methotrexate on dermatitis.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "GPT302",
        "query_type": "explicit_NOT",
        "query_text": "Is it true that Olmesartan does not affect gastroesophageal reflux?",
        "documents": [
            {
                "doc_id": "EX302_1",
                "text": "There are casual claims that Olmesartan has no role in altering gastroesophageal reflux.",
                "relevance": 1
            },
            {
                "doc_id": "EX302_2",
                "text": "Some researchers propose a modest relationship between Olmesartan and gastroesophageal reflux.",
                "relevance": 3
            },
            {
                "doc_id": "EX302_3",
                "text": "Early findings hint that Olmesartan may minimally affect gastroesophageal reflux.",
                "relevance": 2
            },
            {
                "doc_id": "EX302_4",
                "text": "There are casual claims that Olmesartan has no role in altering gastroesophageal reflux.",
                "relevance": 1
            },
            {
                "doc_id": "EX302_5",
                "text": "Clinical results indicate Olmesartan substantially influences gastroesophageal reflux.",
                "relevance": 4
            },
            {
                "doc_id": "EX302_6",
                "text": "Researchers have documented measurable effects of Olmesartan on gastroesophageal reflux outcomes.",
                "relevance": 4
            },
            {
                "doc_id": "EX302_7",
                "text": "Systematic reviews establish that Olmesartan significantly alters gastroesophageal reflux.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "GPT303",
        "query_type": "explicit_NOT",
        "query_text": "Is it true that Tacrolimus does not affect electrolyte imbalance?",
        "documents": [
            {
                "doc_id": "EX303_1",
                "text": "High-quality studies show Tacrolimus consistently affects electrolyte imbalance metrics.",
                "relevance": 5
            },
            {
                "doc_id": "EX303_2",
                "text": "High-quality studies show Tacrolimus consistently affects electrolyte imbalance metrics.",
                "relevance": 5
            },
            {
                "doc_id": "EX303_3",
                "text": "Clinical results indicate Tacrolimus substantially influences electrolyte imbalance.",
                "relevance": 4
            },
            {
                "doc_id": "EX303_4",
                "text": "Researchers have documented measurable effects of Tacrolimus on electrolyte imbalance outcomes.",
                "relevance": 4
            },
            {
                "doc_id": "EX303_5",
                "text": "Long-term use of Tacrolimus might lead to changes in electrolyte imbalance in certain individuals.",
                "relevance": 3
            },
            {
                "doc_id": "EX303_6",
                "text": "Early findings hint that Tacrolimus may minimally affect electrolyte imbalance.",
                "relevance": 2
            },
            {
                "doc_id": "EX303_7",
                "text": "There are casual claims that Tacrolimus has no role in altering electrolyte imbalance.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "GPT304",
        "query_type": "explicit_NOT",
        "query_text": "Is it true that Beta-blockers does not affect neurocognitive function?",
        "documents": [
            {
                "doc_id": "EX304_1",
                "text": "Experts agree that Beta-blockers has a strong and reliable influence on neurocognitive function.",
                "relevance": 5
            },
            {
                "doc_id": "EX304_2",
                "text": "Moderate clinical evidence suggests a potential effect of Beta-blockers on neurocognitive function.",
                "relevance": 3
            },
            {
                "doc_id": "EX304_3",
                "text": "Controlled trials demonstrate a consistent impact of Beta-blockers on neurocognitive function.",
                "relevance": 4
            },
            {
                "doc_id": "EX304_4",
                "text": "A few isolated studies note minor changes in neurocognitive function with Beta-blockers.",
                "relevance": 2
            },
            {
                "doc_id": "EX304_5",
                "text": "Early findings hint that Beta-blockers may minimally affect neurocognitive function.",
                "relevance": 2
            },
            {
                "doc_id": "EX304_6",
                "text": "Moderate clinical evidence suggests a potential effect of Beta-blockers on neurocognitive function.",
                "relevance": 3
            },
            {
                "doc_id": "EX304_7",
                "text": "There are casual claims that Beta-blockers has no role in altering neurocognitive function.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "GPT305",
        "query_type": "explicit_NOT",
        "query_text": "Is it true that Gabapentin does not affect white blood cell count?",
        "documents": [
            {
                "doc_id": "EX305_1",
                "text": "High-quality studies show Gabapentin consistently affects white blood cell count metrics.",
                "relevance": 5
            },
            {
                "doc_id": "EX305_2",
                "text": "A few isolated studies note minor changes in white blood cell count with Gabapentin.",
                "relevance": 2
            },
            {
                "doc_id": "EX305_3",
                "text": "Some forums suggest that Gabapentin is harmless regarding white blood cell count.",
                "relevance": 1
            },
            {
                "doc_id": "EX305_4",
                "text": "Controlled trials demonstrate a consistent impact of Gabapentin on white blood cell count.",
                "relevance": 4
            },
            {
                "doc_id": "EX305_5",
                "text": "Controlled trials demonstrate a consistent impact of Gabapentin on white blood cell count.",
                "relevance": 4
            },
            {
                "doc_id": "EX305_6",
                "text": "Some researchers propose a modest relationship between Gabapentin and white blood cell count.",
                "relevance": 3
            },
            {
                "doc_id": "EX305_7",
                "text": "Moderate clinical evidence suggests a potential effect of Gabapentin on white blood cell count.",
                "relevance": 3
            }
        ]
    },

    {
  "query_id": "HUMAN_GPT1",
  "query_type": "explicit_NOT",
  "query_text": "Has Levothyroxine been convincingly excluded from influencing pancreatic inflammation?",
  "documents": [
    { "doc_id": "HUMAN_EX1_1", "text": "Scattered findings in older literature suggest weak correlations between Levothyroxine and pancreatic inflammation.", "relevance": 2 },
    { "doc_id": "HUMAN_EX1_2", "text": "Clinicians observing long-term cases of Levothyroxine use have documented variations in pancreatic inflammation.", "relevance": 3 },
    { "doc_id": "HUMAN_EX1_3", "text": "Longitudinal trials confirm Levothyroxine's strong effect on pancreatic inflammation, especially in at-risk populations.", "relevance": 5 },
    { "doc_id": "HUMAN_EX1_4", "text": "Blog posts often argue there's no real connection between Levothyroxine and pancreatic inflammation, but they lack peer review.", "relevance": 1 },
    { "doc_id": "HUMAN_EX1_5", "text": "Robust observational data reinforce the association between Levothyroxine and pronounced pancreatic inflammation shifts.", "relevance": 4 },
    { "doc_id": "HUMAN_EX1_6", "text": "Some social media threads insist Levothyroxine doesn't play a role in altering pancreatic inflammation.", "relevance": 1 },
    { "doc_id": "HUMAN_EX1_7", "text": "Recent reviews highlight Levothyroxine as a significant factor affecting pancreatic inflammation trajectories.", "relevance": 4 }
  ]
},
{
  "query_id": "HUMAN_GPT2",
  "query_type": "explicit_NOT",
  "query_text": "Can Interferon-alpha be safely ruled out as a cause of gastrointestinal motility?",
  "documents": [
    { "doc_id": "HUMAN_EX2_1", "text": "A mid-sized trial flagged moderate changes in gastrointestinal motility following prolonged Interferon-alpha administration.", "relevance": 3 },
    { "doc_id": "HUMAN_EX2_2", "text": "Consensus is building around Interferon-alpha's influence on gastrointestinal motility in routine care.", "relevance": 4 },
    { "doc_id": "HUMAN_EX2_3", "text": "Longitudinal trials confirm Interferon-alpha's strong effect on gastrointestinal motility, especially in at-risk populations.", "relevance": 5 },
    { "doc_id": "HUMAN_EX2_4", "text": "A retrospective clinic audit noted minor shifts in gastrointestinal motility among patients using Interferon-alpha.", "relevance": 2 },
    { "doc_id": "HUMAN_EX2_5", "text": "Blog posts often argue there's no real connection between Interferon-alpha and gastrointestinal motility, but they lack peer review.", "relevance": 1 },
    { "doc_id": "HUMAN_EX2_6", "text": "Blog posts often argue there's no real connection between Interferon-alpha and gastrointestinal motility, but they lack peer review.", "relevance": 1 },
    { "doc_id": "HUMAN_EX2_7", "text": "While not conclusive, registry data show some trend toward altered gastrointestinal motility under Interferon-alpha treatment.", "relevance": 3 }
  ]
},
{
  "query_id": "HUMAN_GPT3",
  "query_type": "explicit_NOT",
  "query_text": "Can Amitriptyline be safely ruled out as a cause of pancreatic inflammation?",
  "documents": [
    { "doc_id": "HUMAN_EX3_1", "text": "Recent reviews highlight Amitriptyline as a significant factor affecting pancreatic inflammation trajectories.", "relevance": 4 },
    { "doc_id": "HUMAN_EX3_2", "text": "Consensus is building around Amitriptyline's influence on pancreatic inflammation in routine care.", "relevance": 4 },
    { "doc_id": "HUMAN_EX3_3", "text": "A mid-sized trial flagged moderate changes in pancreatic inflammation following prolonged Amitriptyline administration.", "relevance": 3 },
    { "doc_id": "HUMAN_EX3_4", "text": "Systematic reviews consider Amitriptyline a key modulator of pancreatic inflammation in clinical settings.", "relevance": 5 },
    { "doc_id": "HUMAN_EX3_5", "text": "Blog posts often argue there's no real connection between Amitriptyline and pancreatic inflammation, but they lack peer review.", "relevance": 1 },
    { "doc_id": "HUMAN_EX3_6", "text": "Experts remain unsure whether occasional deviations in pancreatic inflammation can be linked to Amitriptyline.", "relevance": 2 },
    { "doc_id": "HUMAN_EX3_7", "text": "Longitudinal trials confirm Amitriptyline's strong effect on pancreatic inflammation, especially in at-risk populations.", "relevance": 5 }
  ]
},

{
    "query_id": "HUMAN_GPT4",
    "query_type": "explicit_NOT",
    "query_text": "Are concerns about Warfarin and white blood cell count unfounded?",
    "documents": [
        {
            "doc_id": "HUMAN_EX4_1",
            "text": "Recent reviews highlight Warfarin as a significant factor affecting white blood cell count trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX4_2",
            "text": "A mid-sized trial flagged moderate changes in white blood cell count following prolonged Warfarin administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX4_3",
            "text": "Some social media threads insist Warfarin doesn't play a role in altering white blood cell count.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX4_4",
            "text": "Recent reviews highlight Warfarin as a significant factor affecting white blood cell count trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX4_5",
            "text": "A retrospective clinic audit noted minor shifts in white blood cell count among patients using Warfarin.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX4_6",
            "text": "Longitudinal trials confirm Warfarin's strong effect on white blood cell count, especially in at-risk populations.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX4_7",
            "text": "Some social media threads insist Warfarin doesn't play a role in altering white blood cell count.",
            "relevance": 1
        }
    ]
},
{
    "query_id": "HUMAN_GPT5",
    "query_type": "explicit_NOT",
    "query_text": "Has Zoledronic acid ever been shown not to influence dermatitis?",
    "documents": [
        {
            "doc_id": "HUMAN_EX5_1",
            "text": "Recent reviews highlight Zoledronic acid as a significant factor affecting dermatitis trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX5_2",
            "text": "Recent reviews highlight Zoledronic acid as a significant factor affecting dermatitis trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX5_3",
            "text": "Scattered findings in older literature suggest weak correlations between Zoledronic acid and dermatitis.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX5_4",
            "text": "A mid-sized trial flagged moderate changes in dermatitis following prolonged Zoledronic acid administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX5_5",
            "text": "While not conclusive, registry data show some trend toward altered dermatitis under Zoledronic acid treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX5_6",
            "text": "Anecdotal comments frequently downplay any impact of Zoledronic acid on dermatitis.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX5_7",
            "text": "Systematic reviews consider Zoledronic acid a key modulator of dermatitis in clinical settings.",
            "relevance": 5
        }
    ]
},
{
    "query_id": "HUMAN_GPT6",
    "query_type": "explicit_NOT",
    "query_text": "Could OnabotulinumtoxinA have no role in affecting serotonin syndrome risk?",
    "documents": [
        {
            "doc_id": "HUMAN_EX6_1",
            "text": "Consensus is building around OnabotulinumtoxinA's influence on serotonin syndrome risk in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX6_2",
            "text": "Systematic reviews consider OnabotulinumtoxinA a key modulator of serotonin syndrome risk in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX6_3",
            "text": "While not conclusive, registry data show some trend toward altered serotonin syndrome risk under OnabotulinumtoxinA treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX6_4",
            "text": "A retrospective clinic audit noted minor shifts in serotonin syndrome risk among patients using OnabotulinumtoxinA.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX6_5",
            "text": "While not conclusive, registry data show some trend toward altered serotonin syndrome risk under OnabotulinumtoxinA treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX6_6",
            "text": "Blog posts often argue there's no real connection between OnabotulinumtoxinA and serotonin syndrome risk, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX6_7",
            "text": "Consensus is building around OnabotulinumtoxinA's influence on serotonin syndrome risk in routine care.",
            "relevance": 4
        }
    ]
},
{
    "query_id": "HUMAN_GPT7",
    "query_type": "explicit_NOT",
    "query_text": "Could Prednisone have no role in affecting visual field changes?",
    "documents": [
        {
            "doc_id": "HUMAN_EX7_1",
            "text": "Recent reviews highlight Prednisone as a significant factor affecting visual field changes trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX7_2",
            "text": "Blog posts often argue there's no real connection between Prednisone and visual field changes, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX7_3",
            "text": "While not conclusive, registry data show some trend toward altered visual field changes under Prednisone treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX7_4",
            "text": "Systematic reviews consider Prednisone a key modulator of visual field changes in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX7_5",
            "text": "Scattered findings in older literature suggest weak correlations between Prednisone and visual field changes.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX7_6",
            "text": "Recent reviews highlight Prednisone as a significant factor affecting visual field changes trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX7_7",
            "text": "Blog posts often argue there's no real connection between Prednisone and visual field changes, but they lack peer review.",
            "relevance": 1
        }
    ]
},
{
    "query_id": "HUMAN_GPT8",
    "query_type": "explicit_NOT",
    "query_text": "Are concerns about Bupropion and dermatitis unfounded?",
    "documents": [
        {
            "doc_id": "HUMAN_EX8_1",
            "text": "A retrospective clinic audit noted minor shifts in dermatitis among patients using Bupropion.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX8_2",
            "text": "Consensus is building around Bupropion's influence on dermatitis in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX8_3",
            "text": "Consensus is building around Bupropion's influence on dermatitis in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX8_4",
            "text": "Blog posts often argue there's no real connection between Bupropion and dermatitis, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX8_5",
            "text": "Multiple high-quality studies establish a direct impact of Bupropion on dermatitis.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX8_6",
            "text": "While not conclusive, registry data show some trend toward altered dermatitis under Bupropion treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX8_7",
            "text": "Systematic reviews consider Bupropion a key modulator of dermatitis in clinical settings.",
            "relevance": 5
        }
    ]
},
{
    "query_id": "HUMAN_GPT9",
    "query_type": "explicit_NOT",
    "query_text": "Has SGLT2 inhibitors ever been shown not to influence neurocognitive function?",
    "documents": [
        {
            "doc_id": "HUMAN_EX9_1",
            "text": "Recent reviews highlight SGLT2 inhibitors as a significant factor affecting neurocognitive function trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX9_2",
            "text": "A retrospective clinic audit noted minor shifts in neurocognitive function among patients using SGLT2 inhibitors.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX9_3",
            "text": "Consensus is building around SGLT2 inhibitors's influence on neurocognitive function in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX9_4",
            "text": "Some social media threads insist SGLT2 inhibitors doesn't play a role in altering neurocognitive function.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX9_5",
            "text": "Some social media threads insist SGLT2 inhibitors doesn't play a role in altering neurocognitive function.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX9_6",
            "text": "Clinicians observing long-term cases of SGLT2 inhibitors use have documented variations in neurocognitive function.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX9_7",
            "text": "Longitudinal trials confirm SGLT2 inhibitors's strong effect on neurocognitive function, especially in at-risk populations.",
            "relevance": 5
        }
    ]
},
{
    "query_id": "HUMAN_GPT10",
    "query_type": "explicit_NOT",
    "query_text": "Can Dexamethasone be safely ruled out as a cause of white blood cell count?",
    "documents": [
        {
            "doc_id": "HUMAN_EX10_1",
            "text": "Anecdotal comments frequently downplay any impact of Dexamethasone on white blood cell count.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX10_2",
            "text": "Anecdotal comments frequently downplay any impact of Dexamethasone on white blood cell count.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX10_3",
            "text": "While not conclusive, registry data show some trend toward altered white blood cell count under Dexamethasone treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX10_4",
            "text": "A retrospective clinic audit noted minor shifts in white blood cell count among patients using Dexamethasone.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX10_5",
            "text": "Recent reviews highlight Dexamethasone as a significant factor affecting white blood cell count trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX10_6",
            "text": "Consensus is building around Dexamethasone's influence on white blood cell count in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX10_7",
            "text": "Multiple high-quality studies establish a direct impact of Dexamethasone on white blood cell count.",
            "relevance": 5
        }
    ]
},



    {
        "query_id": "HUMAN_GPT11",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Hydrochlorothiazide and skin photosensitivity unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX11_1",
                "text": "Longitudinal trials confirm Hydrochlorothiazide's strong effect on skin photosensitivity, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX11_2",
                "text": "Recent reviews highlight Hydrochlorothiazide as a significant factor affecting skin photosensitivity trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX11_3",
                "text": "A mid-sized trial flagged moderate changes in skin photosensitivity following prolonged Hydrochlorothiazide administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX11_4",
                "text": "Anecdotal comments frequently downplay any impact of Hydrochlorothiazide on skin photosensitivity.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX11_5",
                "text": "Clinicians observing long-term cases of Hydrochlorothiazide use have documented variations in skin photosensitivity.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX11_6",
                "text": "A retrospective clinic audit noted minor shifts in skin photosensitivity among patients using Hydrochlorothiazide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX11_7",
                "text": "A retrospective clinic audit noted minor shifts in skin photosensitivity among patients using Hydrochlorothiazide.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT12",
        "query_type": "explicit_NOT",
        "query_text": "Can Cyclophosphamide be safely ruled out as a cause of neurocognitive function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX12_1",
                "text": "Recent reviews highlight Cyclophosphamide as a significant factor affecting neurocognitive function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX12_2",
                "text": "Consensus is building around Cyclophosphamide's influence on neurocognitive function in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX12_3",
                "text": "A mid-sized trial flagged moderate changes in neurocognitive function following prolonged Cyclophosphamide administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX12_4",
                "text": "Longitudinal trials confirm Cyclophosphamide's strong effect on neurocognitive function, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX12_5",
                "text": "Some social media threads insist Cyclophosphamide doesn't play a role in altering neurocognitive function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX12_6",
                "text": "A retrospective clinic audit noted minor shifts in neurocognitive function among patients using Cyclophosphamide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX12_7",
                "text": "Systematic reviews consider Cyclophosphamide a key modulator of neurocognitive function in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT13",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Zoledronic acid and skin photosensitivity unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX13_1",
                "text": "Clinicians observing long-term cases of Zoledronic acid use have documented variations in skin photosensitivity.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX13_2",
                "text": "Systematic reviews consider Zoledronic acid a key modulator of skin photosensitivity in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX13_3",
                "text": "Consensus is building around Zoledronic acid's influence on skin photosensitivity in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX13_4",
                "text": "A retrospective clinic audit noted minor shifts in skin photosensitivity among patients using Zoledronic acid.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX13_5",
                "text": "Recent reviews highlight Zoledronic acid as a significant factor affecting skin photosensitivity trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX13_6",
                "text": "Some social media threads insist Zoledronic acid doesn't play a role in altering skin photosensitivity.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX13_7",
                "text": "Blog posts often argue there's no real connection between Zoledronic acid and skin photosensitivity, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT14",
        "query_type": "explicit_NOT",
        "query_text": "Has Methotrexate been convincingly excluded from influencing blood glucose variability?",
        "documents": [
            {
                "doc_id": "HUMAN_EX14_1",
                "text": "Blog posts often argue there's no real connection between Methotrexate and blood glucose variability, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX14_2",
                "text": "Clinicians observing long-term cases of Methotrexate use have documented variations in blood glucose variability.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX14_3",
                "text": "Clinicians observing long-term cases of Methotrexate use have documented variations in blood glucose variability.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX14_4",
                "text": "Some social media threads insist Methotrexate doesn't play a role in altering blood glucose variability.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX14_5",
                "text": "Robust observational data reinforce the association between Methotrexate and pronounced blood glucose variability shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX14_6",
                "text": "Multiple high-quality studies establish a direct impact of Methotrexate on blood glucose variability.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX14_7",
                "text": "Experts remain unsure whether occasional deviations in blood glucose variability can be linked to Methotrexate.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT15",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Bupropion and sleep architecture unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX15_1",
                "text": "Consensus is building around Bupropion's influence on sleep architecture in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX15_2",
                "text": "A mid-sized trial flagged moderate changes in sleep architecture following prolonged Bupropion administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX15_3",
                "text": "Clinicians observing long-term cases of Bupropion use have documented variations in sleep architecture.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX15_4",
                "text": "Systematic reviews consider Bupropion a key modulator of sleep architecture in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX15_5",
                "text": "Experts remain unsure whether occasional deviations in sleep architecture can be linked to Bupropion.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX15_6",
                "text": "Blog posts often argue there's no real connection between Bupropion and sleep architecture, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX15_7",
                "text": "Some social media threads insist Bupropion doesn't play a role in altering sleep architecture.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT16",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Selegiline and thyroid function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX16_1",
                "text": "Clinicians observing long-term cases of Selegiline use have documented variations in thyroid function.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX16_2",
                "text": "While not conclusive, registry data show some trend toward altered thyroid function under Selegiline treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX16_3",
                "text": "Robust observational data reinforce the association between Selegiline and pronounced thyroid function shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX16_4",
                "text": "Some social media threads insist Selegiline doesn't play a role in altering thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX16_5",
                "text": "Robust observational data reinforce the association between Selegiline and pronounced thyroid function shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX16_6",
                "text": "Scattered findings in older literature suggest weak correlations between Selegiline and thyroid function.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX16_7",
                "text": "Systematic reviews consider Selegiline a key modulator of thyroid function in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT17",
        "query_type": "explicit_NOT",
        "query_text": "Has Azithromycin ever been shown not to influence cognitive decline?",
        "documents": [
            {
                "doc_id": "HUMAN_EX17_1",
                "text": "Some social media threads insist Azithromycin doesn't play a role in altering cognitive decline.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX17_2",
                "text": "Systematic reviews consider Azithromycin a key modulator of cognitive decline in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX17_3",
                "text": "A retrospective clinic audit noted minor shifts in cognitive decline among patients using Azithromycin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX17_4",
                "text": "Blog posts often argue there's no real connection between Azithromycin and cognitive decline, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX17_5",
                "text": "While not conclusive, registry data show some trend toward altered cognitive decline under Azithromycin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX17_6",
                "text": "Recent reviews highlight Azithromycin as a significant factor affecting cognitive decline trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX17_7",
                "text": "Robust observational data reinforce the association between Azithromycin and pronounced cognitive decline shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT18",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Lithium carbonate's lack of impact on visual field changes?",
        "documents": [
            {
                "doc_id": "HUMAN_EX18_1",
                "text": "Some social media threads insist Lithium carbonate doesn't play a role in altering visual field changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX18_2",
                "text": "Experts remain unsure whether occasional deviations in visual field changes can be linked to Lithium carbonate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX18_3",
                "text": "Consensus is building around Lithium carbonate's influence on visual field changes in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX18_4",
                "text": "While not conclusive, registry data show some trend toward altered visual field changes under Lithium carbonate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX18_5",
                "text": "Scattered findings in older literature suggest weak correlations between Lithium carbonate and visual field changes.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX18_6",
                "text": "While not conclusive, registry data show some trend toward altered visual field changes under Lithium carbonate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX18_7",
                "text": "Systematic reviews consider Lithium carbonate a key modulator of visual field changes in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT19",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Infliximab leaves thyroid function unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX19_1",
                "text": "Longitudinal trials confirm Infliximab's strong effect on thyroid function, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX19_2",
                "text": "Recent reviews highlight Infliximab as a significant factor affecting thyroid function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX19_3",
                "text": "A retrospective clinic audit noted minor shifts in thyroid function among patients using Infliximab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX19_4",
                "text": "Blog posts often argue there's no real connection between Infliximab and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX19_5",
                "text": "Recent reviews highlight Infliximab as a significant factor affecting thyroid function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX19_6",
                "text": "Blog posts often argue there's no real connection between Infliximab and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX19_7",
                "text": "A mid-sized trial flagged moderate changes in thyroid function following prolonged Infliximab administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT20",
        "query_type": "explicit_NOT",
        "query_text": "Could Olanzapine have no role in affecting hypernatremia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX20_1",
                "text": "Systematic reviews consider Olanzapine a key modulator of hypernatremia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX20_2",
                "text": "A retrospective clinic audit noted minor shifts in hypernatremia among patients using Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX20_3",
                "text": "Some social media threads insist Olanzapine doesn't play a role in altering hypernatremia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX20_4",
                "text": "Some social media threads insist Olanzapine doesn't play a role in altering hypernatremia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX20_5",
                "text": "Consensus is building around Olanzapine's influence on hypernatremia in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX20_6",
                "text": "While not conclusive, registry data show some trend toward altered hypernatremia under Olanzapine treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX20_7",
                "text": "Robust observational data reinforce the association between Olanzapine and pronounced hypernatremia shifts.",
                "relevance": 4
            }
        ]
    },

    {
        "query_id": "HUMAN_GPT21",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Selegiline and renal tubular necrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX21_1",
                "text": "Experts remain unsure whether occasional deviations in renal tubular necrosis can be linked to Selegiline.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX21_2",
                "text": "Scattered findings in older literature suggest weak correlations between Selegiline and renal tubular necrosis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX21_3",
                "text": "Systematic reviews consider Selegiline a key modulator of renal tubular necrosis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX21_4",
                "text": "Robust observational data reinforce the association between Selegiline and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX21_5",
                "text": "Blog posts often argue there's no real connection between Selegiline and renal tubular necrosis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX21_6",
                "text": "Blog posts often argue there's no real connection between Selegiline and renal tubular necrosis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX21_7",
                "text": "A mid-sized trial flagged moderate changes in renal tubular necrosis following prolonged Selegiline administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT22",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between ACE inhibitors and cognitive decline?",
        "documents": [
            {
                "doc_id": "HUMAN_EX22_1",
                "text": "Experts remain unsure whether occasional deviations in cognitive decline can be linked to ACE inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX22_2",
                "text": "Robust observational data reinforce the association between ACE inhibitors and pronounced cognitive decline shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX22_3",
                "text": "Clinicians observing long-term cases of ACE inhibitors use have documented variations in cognitive decline.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX22_4",
                "text": "Systematic reviews consider ACE inhibitors a key modulator of cognitive decline in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX22_5",
                "text": "Recent reviews highlight ACE inhibitors as a significant factor affecting cognitive decline trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX22_6",
                "text": "Multiple high-quality studies establish a direct impact of ACE inhibitors on cognitive decline.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX22_7",
                "text": "Blog posts often argue there's no real connection between ACE inhibitors and cognitive decline, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT23",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Azithromycin leaves hormonal axis disruption unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX23_1",
                "text": "Longitudinal trials confirm Azithromycin's strong effect on hormonal axis disruption, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX23_2",
                "text": "Recent reviews highlight Azithromycin as a significant factor affecting hormonal axis disruption trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX23_3",
                "text": "Systematic reviews consider Azithromycin a key modulator of hormonal axis disruption in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX23_4",
                "text": "Anecdotal comments frequently downplay any impact of Azithromycin on hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX23_5",
                "text": "Recent reviews highlight Azithromycin as a significant factor affecting hormonal axis disruption trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX23_6",
                "text": "While not conclusive, registry data show some trend toward altered hormonal axis disruption under Azithromycin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX23_7",
                "text": "Scattered findings in older literature suggest weak correlations between Azithromycin and hormonal axis disruption.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT24",
        "query_type": "explicit_NOT",
        "query_text": "Has Olanzapine been convincingly excluded from influencing hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX24_1",
                "text": "Experts remain unsure whether occasional deviations in hypoglycemia risk can be linked to Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX24_2",
                "text": "Clinicians observing long-term cases of Olanzapine use have documented variations in hypoglycemia risk.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX24_3",
                "text": "Anecdotal comments frequently downplay any impact of Olanzapine on hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX24_4",
                "text": "Recent reviews highlight Olanzapine as a significant factor affecting hypoglycemia risk trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX24_5",
                "text": "Recent reviews highlight Olanzapine as a significant factor affecting hypoglycemia risk trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX24_6",
                "text": "Longitudinal trials confirm Olanzapine's strong effect on hypoglycemia risk, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX24_7",
                "text": "Blog posts often argue there's no real connection between Olanzapine and hypoglycemia risk, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT25",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Zoledronic acid's lack of impact on QT prolongation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX25_1",
                "text": "Systematic reviews consider Zoledronic acid a key modulator of QT prolongation in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX25_2",
                "text": "Consensus is building around Zoledronic acid's influence on QT prolongation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX25_3",
                "text": "A retrospective clinic audit noted minor shifts in QT prolongation among patients using Zoledronic acid.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX25_4",
                "text": "A mid-sized trial flagged moderate changes in QT prolongation following prolonged Zoledronic acid administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX25_5",
                "text": "Anecdotal comments frequently downplay any impact of Zoledronic acid on QT prolongation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX25_6",
                "text": "Robust observational data reinforce the association between Zoledronic acid and pronounced QT prolongation shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX25_7",
                "text": "Blog posts often argue there's no real connection between Zoledronic acid and QT prolongation, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT26",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Olmesartan has no bearing on thyroid function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX26_1",
                "text": "Consensus is building around Olmesartan's influence on thyroid function in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX26_2",
                "text": "Blog posts often argue there's no real connection between Olmesartan and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX26_3",
                "text": "Multiple high-quality studies establish a direct impact of Olmesartan on thyroid function.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX26_4",
                "text": "A mid-sized trial flagged moderate changes in thyroid function following prolonged Olmesartan administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX26_5",
                "text": "A retrospective clinic audit noted minor shifts in thyroid function among patients using Olmesartan.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX26_6",
                "text": "Experts remain unsure whether occasional deviations in thyroid function can be linked to Olmesartan.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX26_7",
                "text": "Some social media threads insist Olmesartan doesn't play a role in altering thyroid function.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT27",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that OnabotulinumtoxinA doesn't alter dermatitis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX27_1",
                "text": "Clinicians observing long-term cases of OnabotulinumtoxinA use have documented variations in dermatitis.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX27_2",
                "text": "Robust observational data reinforce the association between OnabotulinumtoxinA and pronounced dermatitis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX27_3",
                "text": "Scattered findings in older literature suggest weak correlations between OnabotulinumtoxinA and dermatitis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX27_4",
                "text": "A mid-sized trial flagged moderate changes in dermatitis following prolonged OnabotulinumtoxinA administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX27_5",
                "text": "Scattered findings in older literature suggest weak correlations between OnabotulinumtoxinA and dermatitis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX27_6",
                "text": "Some social media threads insist OnabotulinumtoxinA doesn't play a role in altering dermatitis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX27_7",
                "text": "Multiple high-quality studies establish a direct impact of OnabotulinumtoxinA on dermatitis.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT28",
        "query_type": "explicit_NOT",
        "query_text": "Has Warfarin ever been shown not to influence menstrual irregularities?",
        "documents": [
            {
                "doc_id": "HUMAN_EX28_1",
                "text": "Some social media threads insist Warfarin doesn't play a role in altering menstrual irregularities.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX28_2",
                "text": "Longitudinal trials confirm Warfarin's strong effect on menstrual irregularities, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX28_3",
                "text": "Recent reviews highlight Warfarin as a significant factor affecting menstrual irregularities trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX28_4",
                "text": "A retrospective clinic audit noted minor shifts in menstrual irregularities among patients using Warfarin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX28_5",
                "text": "A mid-sized trial flagged moderate changes in menstrual irregularities following prolonged Warfarin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX28_6",
                "text": "Robust observational data reinforce the association between Warfarin and pronounced menstrual irregularities shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX28_7",
                "text": "Anecdotal comments frequently downplay any impact of Warfarin on menstrual irregularities.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT29",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Beta-blockers has no bearing on hypernatremia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX29_1",
                "text": "Some social media threads insist Beta-blockers doesn't play a role in altering hypernatremia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX29_2",
                "text": "Robust observational data reinforce the association between Beta-blockers and pronounced hypernatremia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX29_3",
                "text": "Recent reviews highlight Beta-blockers as a significant factor affecting hypernatremia trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX29_4",
                "text": "Clinicians observing long-term cases of Beta-blockers use have documented variations in hypernatremia.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX29_5",
                "text": "Multiple high-quality studies establish a direct impact of Beta-blockers on hypernatremia.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX29_6",
                "text": "A retrospective clinic audit noted minor shifts in hypernatremia among patients using Beta-blockers.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX29_7",
                "text": "Systematic reviews consider Beta-blockers a key modulator of hypernatremia in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT30",
        "query_type": "explicit_NOT",
        "query_text": "Could Warfarin have no role in affecting gastrointestinal motility?",
        "documents": [
            {
                "doc_id": "HUMAN_EX30_1",
                "text": "Scattered findings in older literature suggest weak correlations between Warfarin and gastrointestinal motility.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX30_2",
                "text": "While not conclusive, registry data show some trend toward altered gastrointestinal motility under Warfarin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX30_3",
                "text": "While not conclusive, registry data show some trend toward altered gastrointestinal motility under Warfarin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX30_4",
                "text": "Experts remain unsure whether occasional deviations in gastrointestinal motility can be linked to Warfarin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX30_5",
                "text": "Consensus is building around Warfarin's influence on gastrointestinal motility in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX30_6",
                "text": "Blog posts often argue there's no real connection between Warfarin and gastrointestinal motility, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX30_7",
                "text": "Longitudinal trials confirm Warfarin's strong effect on gastrointestinal motility, especially in at-risk populations.",
                "relevance": 5
            }
        ]
    },


    {
    "query_id": "HUMAN_GPT49",
    "query_type": "explicit_NOT",
    "query_text": "What does the evidence say about Hydrochlorothiazide's lack of impact on sleep architecture?",
    "documents": [
        {
            "doc_id": "HUMAN_EX49_1",
            "text": "A mid-sized trial flagged moderate changes in sleep architecture following prolonged Hydrochlorothiazide administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX49_2",
            "text": "Systematic reviews consider Hydrochlorothiazide a key modulator of sleep architecture in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX49_3",
            "text": "Scattered findings in older literature suggest weak correlations between Hydrochlorothiazide and sleep architecture.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX49_4",
            "text": "Consensus is building around Hydrochlorothiazide's influence on sleep architecture in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX49_5",
            "text": "Blog posts often argue there's no real connection between Hydrochlorothiazide and sleep architecture, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX49_6",
            "text": "Recent reviews highlight Hydrochlorothiazide as a significant factor affecting sleep architecture trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX49_7",
            "text": "While not conclusive, registry data show some trend toward altered sleep architecture under Hydrochlorothiazide treatment.",
            "relevance": 3
        }
    ]
},
{
    "query_id": "HUMAN_GPT50",
    "query_type": "explicit_NOT",
    "query_text": "What does the evidence say about SGLT2 inhibitors's lack of impact on bone marrow suppression?",
    "documents": [
        {
            "doc_id": "HUMAN_EX50_1",
            "text": "Recent reviews highlight SGLT2 inhibitors as a significant factor affecting bone marrow suppression trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX50_2",
            "text": "Blog posts often argue there's no real connection between SGLT2 inhibitors and bone marrow suppression, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX50_3",
            "text": "Multiple high-quality studies establish a direct impact of SGLT2 inhibitors on bone marrow suppression.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX50_4",
            "text": "Scattered findings in older literature suggest weak correlations between SGLT2 inhibitors and bone marrow suppression.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX50_5",
            "text": "Clinicians observing long-term cases of SGLT2 inhibitors use have documented variations in bone marrow suppression.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX50_6",
            "text": "Consensus is building around SGLT2 inhibitors's influence on bone marrow suppression in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX50_7",
            "text": "Multiple high-quality studies establish a direct impact of SGLT2 inhibitors on bone marrow suppression.",
            "relevance": 5
        }
    ]
},
{
    "query_id": "HUMAN_GPT51",
    "query_type": "explicit_NOT",
    "query_text": "Has Hydrochlorothiazide ever been shown not to influence menstrual irregularities?",
    "documents": [
        {
            "doc_id": "HUMAN_EX51_1",
            "text": "Multiple high-quality studies establish a direct impact of Hydrochlorothiazide on menstrual irregularities.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX51_2",
            "text": "Clinicians observing long-term cases of Hydrochlorothiazide use have documented variations in menstrual irregularities.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX51_3",
            "text": "A retrospective clinic audit noted minor shifts in menstrual irregularities among patients using Hydrochlorothiazide.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX51_4",
            "text": "Robust observational data reinforce the association between Hydrochlorothiazide and pronounced menstrual irregularities shifts.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX51_5",
            "text": "Robust observational data reinforce the association between Hydrochlorothiazide and pronounced menstrual irregularities shifts.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX51_6",
            "text": "Blog posts often argue there's no real connection between Hydrochlorothiazide and menstrual irregularities, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX51_7",
            "text": "Clinicians observing long-term cases of Hydrochlorothiazide use have documented variations in menstrual irregularities.",
            "relevance": 3
        }
    ]
},
{
    "query_id": "HUMAN_GPT52",
    "query_type": "explicit_NOT",
    "query_text": "Are concerns about Lithium carbonate and skin photosensitivity unfounded?",
    "documents": [
        {
            "doc_id": "HUMAN_EX52_1",
            "text": "Scattered findings in older literature suggest weak correlations between Lithium carbonate and skin photosensitivity.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX52_2",
            "text": "Blog posts often argue there's no real connection between Lithium carbonate and skin photosensitivity, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX52_3",
            "text": "Robust observational data reinforce the association between Lithium carbonate and pronounced skin photosensitivity shifts.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX52_4",
            "text": "While not conclusive, registry data show some trend toward altered skin photosensitivity under Lithium carbonate treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX52_5",
            "text": "Recent reviews highlight Lithium carbonate as a significant factor affecting skin photosensitivity trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX52_6",
            "text": "A mid-sized trial flagged moderate changes in skin photosensitivity following prolonged Lithium carbonate administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX52_7",
            "text": "Systematic reviews consider Lithium carbonate a key modulator of skin photosensitivity in clinical settings.",
            "relevance": 5
        }
    ]
},
{
    "query_id": "HUMAN_GPT53",
    "query_type": "explicit_NOT",
    "query_text": "Are concerns about Infliximab and visual field changes unfounded?",
    "documents": [
        {
            "doc_id": "HUMAN_EX53_1",
            "text": "Longitudinal trials confirm Infliximab's strong effect on visual field changes, especially in at-risk populations.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX53_2",
            "text": "Experts remain unsure whether occasional deviations in visual field changes can be linked to Infliximab.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX53_3",
            "text": "Consensus is building around Infliximab's influence on visual field changes in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX53_4",
            "text": "Experts remain unsure whether occasional deviations in visual field changes can be linked to Infliximab.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX53_5",
            "text": "Anecdotal comments frequently downplay any impact of Infliximab on visual field changes.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX53_6",
            "text": "A mid-sized trial flagged moderate changes in visual field changes following prolonged Infliximab administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX53_7",
            "text": "Clinicians observing long-term cases of Infliximab use have documented variations in visual field changes.",
            "relevance": 3
        }
    ]
},
{
    "query_id": "HUMAN_GPT54",
    "query_type": "explicit_NOT",
    "query_text": "Has Tacrolimus ever been shown not to influence pulmonary fibrosis?",
    "documents": [
        {
            "doc_id": "HUMAN_EX54_1",
            "text": "Clinicians observing long-term cases of Tacrolimus use have documented variations in pulmonary fibrosis.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX54_2",
            "text": "Clinicians observing long-term cases of Tacrolimus use have documented variations in pulmonary fibrosis.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX54_3",
            "text": "Systematic reviews consider Tacrolimus a key modulator of pulmonary fibrosis in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX54_4",
            "text": "Experts remain unsure whether occasional deviations in pulmonary fibrosis can be linked to Tacrolimus.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX54_5",
            "text": "Some social media threads insist Tacrolimus doesn't play a role in altering pulmonary fibrosis.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX54_6",
            "text": "Consensus is building around Tacrolimus's influence on pulmonary fibrosis in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX54_7",
            "text": "Recent reviews highlight Tacrolimus as a significant factor affecting pulmonary fibrosis trajectories.",
            "relevance": 4
        }
    ]
},
{
    "query_id": "HUMAN_GPT55",
    "query_type": "explicit_NOT",
    "query_text": "Do clinical trials support the idea that Interferon-alpha doesn't alter thyroid function?",
    "documents": [
        {
            "doc_id": "HUMAN_EX55_1",
            "text": "Anecdotal comments frequently downplay any impact of Interferon-alpha on thyroid function.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX55_2",
            "text": "Experts remain unsure whether occasional deviations in thyroid function can be linked to Interferon-alpha.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX55_3",
            "text": "Consensus is building around Interferon-alpha's influence on thyroid function in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX55_4",
            "text": "Systematic reviews consider Interferon-alpha a key modulator of thyroid function in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX55_5",
            "text": "Recent reviews highlight Interferon-alpha as a significant factor affecting thyroid function trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX55_6",
            "text": "Clinicians observing long-term cases of Interferon-alpha use have documented variations in thyroid function.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX55_7",
            "text": "Longitudinal trials confirm Interferon-alpha's strong effect on thyroid function, especially in at-risk populations.",
            "relevance": 5
        }
    ]
},
{
    "query_id": "HUMAN_GPT56",
    "query_type": "explicit_NOT",
    "query_text": "Are concerns about Topiramate and thyroid function unfounded?",
    "documents": [
        {
            "doc_id": "HUMAN_EX56_1",
            "text": "Scattered findings in older literature suggest weak correlations between Topiramate and thyroid function.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX56_2",
            "text": "Blog posts often argue there's no real connection between Topiramate and thyroid function, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX56_3",
            "text": "Systematic reviews consider Topiramate a key modulator of thyroid function in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX56_4",
            "text": "Robust observational data reinforce the association between Topiramate and pronounced thyroid function shifts.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX56_5",
            "text": "Consensus is building around Topiramate's influence on thyroid function in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX56_6",
            "text": "Multiple high-quality studies establish a direct impact of Topiramate on thyroid function.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX56_7",
            "text": "Clinicians observing long-term cases of Topiramate use have documented variations in thyroid function.",
            "relevance": 3
        }
    ]
},
{
    "query_id": "HUMAN_GPT57",
    "query_type": "explicit_NOT",
    "query_text": "Has Gabapentin been convincingly excluded from influencing electrolyte imbalance?",
    "documents": [
        {
            "doc_id": "HUMAN_EX57_1",
            "text": "Anecdotal comments frequently downplay any impact of Gabapentin on electrolyte imbalance.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX57_2",
            "text": "Robust observational data reinforce the association between Gabapentin and pronounced electrolyte imbalance shifts.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX57_3",
            "text": "Systematic reviews consider Gabapentin a key modulator of electrolyte imbalance in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX57_4",
            "text": "Clinicians observing long-term cases of Gabapentin use have documented variations in electrolyte imbalance.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX57_5",
            "text": "While not conclusive, registry data show some trend toward altered electrolyte imbalance under Gabapentin treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX57_6",
            "text": "Anecdotal comments frequently downplay any impact of Gabapentin on electrolyte imbalance.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX57_7",
            "text": "A retrospective clinic audit noted minor shifts in electrolyte imbalance among patients using Gabapentin.",
            "relevance": 2
        }
    ]
},
{
    "query_id": "HUMAN_GPT58",
    "query_type": "explicit_NOT",
    "query_text": "Is it accurate to say Tramadol has no bearing on peripheral neuropathy?",
    "documents": [
        {
            "doc_id": "HUMAN_EX58_1",
            "text": "While not conclusive, registry data show some trend toward altered peripheral neuropathy under Tramadol treatment.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX58_2",
            "text": "Experts remain unsure whether occasional deviations in peripheral neuropathy can be linked to Tramadol.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX58_3",
            "text": "Blog posts often argue there's no real connection between Tramadol and peripheral neuropathy, but they lack peer review.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX58_4",
            "text": "Consensus is building around Tramadol's influence on peripheral neuropathy in routine care.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX58_5",
            "text": "Scattered findings in older literature suggest weak correlations between Tramadol and peripheral neuropathy.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX58_6",
            "text": "Longitudinal trials confirm Tramadol's strong effect on peripheral neuropathy, especially in at-risk populations.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX58_7",
            "text": "Some social media threads insist Tramadol doesn't play a role in altering peripheral neuropathy.",
            "relevance": 1
        }
    ]
},
{
    "query_id": "HUMAN_GPT59",
    "query_type": "explicit_NOT",
    "query_text": "What does the evidence say about ACE inhibitors's lack of impact on hypoglycemia risk?",
    "documents": [
        {
            "doc_id": "HUMAN_EX59_1",
            "text": "Scattered findings in older literature suggest weak correlations between ACE inhibitors and hypoglycemia risk.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX59_2",
            "text": "Longitudinal trials confirm ACE inhibitors's strong effect on hypoglycemia risk, especially in at-risk populations.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX59_3",
            "text": "A mid-sized trial flagged moderate changes in hypoglycemia risk following prolonged ACE inhibitors administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX59_4",
            "text": "Recent reviews highlight ACE inhibitors as a significant factor affecting hypoglycemia risk trajectories.",
            "relevance": 4
        },
        {
            "doc_id": "HUMAN_EX59_5",
            "text": "Some social media threads insist ACE inhibitors doesn't play a role in altering hypoglycemia risk.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX59_6",
            "text": "Anecdotal comments frequently downplay any impact of ACE inhibitors on hypoglycemia risk.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX59_7",
            "text": "Recent reviews highlight ACE inhibitors as a significant factor affecting hypoglycemia risk trajectories.",
            "relevance": 4
        }
    ]
},
{
    "query_id": "HUMAN_GPT60",
    "query_type": "explicit_NOT",
    "query_text": "What does the evidence say about Beta-blockers's lack of impact on menstrual irregularities?",
    "documents": [
        {
            "doc_id": "HUMAN_EX60_1",
            "text": "A mid-sized trial flagged moderate changes in menstrual irregularities following prolonged Beta-blockers administration.",
            "relevance": 3
        },
        {
            "doc_id": "HUMAN_EX60_2",
            "text": "Systematic reviews consider Beta-blockers a key modulator of menstrual irregularities in clinical settings.",
            "relevance": 5
        },
        {
            "doc_id": "HUMAN_EX60_3",
            "text": "A retrospective clinic audit noted minor shifts in menstrual irregularities among patients using Beta-blockers.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX60_4",
            "text": "Some social media threads insist Beta-blockers doesn't play a role in altering menstrual irregularities.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX60_5",
            "text": "Scattered findings in older literature suggest weak correlations between Beta-blockers and menstrual irregularities.",
            "relevance": 2
        },
        {
            "doc_id": "HUMAN_EX60_6",
            "text": "Anecdotal comments frequently downplay any impact of Beta-blockers on menstrual irregularities.",
            "relevance": 1
        },
        {
            "doc_id": "HUMAN_EX60_7",
            "text": "Recent reviews highlight Beta-blockers as a significant factor affecting menstrual irregularities trajectories.",
            "relevance": 4
        }
    ]
},



    {
        "query_id": "HUMAN_GPT61",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Beta-blockers has no bearing on appetite changes?",
        "documents": [
            {
                "doc_id": "HUMAN_EX61_1",
                "text": "Consensus is building around Beta-blockers's influence on appetite changes in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX61_2",
                "text": "Longitudinal trials confirm Beta-blockers's strong effect on appetite changes, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX61_3",
                "text": "Some social media threads insist Beta-blockers doesn't play a role in altering appetite changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX61_4",
                "text": "A retrospective clinic audit noted minor shifts in appetite changes among patients using Beta-blockers.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX61_5",
                "text": "A mid-sized trial flagged moderate changes in appetite changes following prolonged Beta-blockers administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX61_6",
                "text": "Longitudinal trials confirm Beta-blockers's strong effect on appetite changes, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX61_7",
                "text": "Recent reviews highlight Beta-blockers as a significant factor affecting appetite changes trajectories.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT62",
        "query_type": "explicit_NOT",
        "query_text": "Has Clopidogrel ever been shown not to influence bone marrow suppression?",
        "documents": [
            {
                "doc_id": "HUMAN_EX62_1",
                "text": "Systematic reviews consider Clopidogrel a key modulator of bone marrow suppression in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX62_2",
                "text": "A mid-sized trial flagged moderate changes in bone marrow suppression following prolonged Clopidogrel administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX62_3",
                "text": "Blog posts often argue there's no real connection between Clopidogrel and bone marrow suppression, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX62_4",
                "text": "Recent reviews highlight Clopidogrel as a significant factor affecting bone marrow suppression trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX62_5",
                "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Clopidogrel.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX62_6",
                "text": "Some social media threads insist Clopidogrel doesn't play a role in altering bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX62_7",
                "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Clopidogrel.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT63",
        "query_type": "explicit_NOT",
        "query_text": "Can Bupropion be safely ruled out as a cause of sleep architecture?",
        "documents": [
            {
                "doc_id": "HUMAN_EX63_1",
                "text": "Consensus is building around Bupropion's influence on sleep architecture in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX63_2",
                "text": "Systematic reviews consider Bupropion a key modulator of sleep architecture in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX63_3",
                "text": "Anecdotal comments frequently downplay any impact of Bupropion on sleep architecture.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX63_4",
                "text": "A mid-sized trial flagged moderate changes in sleep architecture following prolonged Bupropion administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX63_5",
                "text": "Scattered findings in older literature suggest weak correlations between Bupropion and sleep architecture.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX63_6",
                "text": "While not conclusive, registry data show some trend toward altered sleep architecture under Bupropion treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX63_7",
                "text": "Recent reviews highlight Bupropion as a significant factor affecting sleep architecture trajectories.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT64",
        "query_type": "explicit_NOT",
        "query_text": "Could Infliximab have no role in affecting seizure threshold?",
        "documents": [
            {
                "doc_id": "HUMAN_EX64_1",
                "text": "Robust observational data reinforce the association between Infliximab and pronounced seizure threshold shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX64_2",
                "text": "Longitudinal trials confirm Infliximab's strong effect on seizure threshold, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX64_3",
                "text": "Longitudinal trials confirm Infliximab's strong effect on seizure threshold, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX64_4",
                "text": "A retrospective clinic audit noted minor shifts in seizure threshold among patients using Infliximab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX64_5",
                "text": "Clinicians observing long-term cases of Infliximab use have documented variations in seizure threshold.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX64_6",
                "text": "Blog posts often argue there's no real connection between Infliximab and seizure threshold, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX64_7",
                "text": "Consensus is building around Infliximab's influence on seizure threshold in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT65",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Tramadol leaves appetite changes unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX65_1",
                "text": "A retrospective clinic audit noted minor shifts in appetite changes among patients using Tramadol.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX65_2",
                "text": "A mid-sized trial flagged moderate changes in appetite changes following prolonged Tramadol administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX65_3",
                "text": "Robust observational data reinforce the association between Tramadol and pronounced appetite changes shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX65_4",
                "text": "Systematic reviews consider Tramadol a key modulator of appetite changes in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX65_5",
                "text": "Anecdotal comments frequently downplay any impact of Tramadol on appetite changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX65_6",
                "text": "Experts remain unsure whether occasional deviations in appetite changes can be linked to Tramadol.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX65_7",
                "text": "Clinicians observing long-term cases of Tramadol use have documented variations in appetite changes.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT66",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Clopidogrel and visual field changes?",
        "documents": [
            {
                "doc_id": "HUMAN_EX66_1",
                "text": "Some social media threads insist Clopidogrel doesn't play a role in altering visual field changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX66_2",
                "text": "A retrospective clinic audit noted minor shifts in visual field changes among patients using Clopidogrel.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX66_3",
                "text": "Recent reviews highlight Clopidogrel as a significant factor affecting visual field changes trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX66_4",
                "text": "A mid-sized trial flagged moderate changes in visual field changes following prolonged Clopidogrel administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX66_5",
                "text": "Clinicians observing long-term cases of Clopidogrel use have documented variations in visual field changes.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX66_6",
                "text": "Multiple high-quality studies establish a direct impact of Clopidogrel on visual field changes.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX66_7",
                "text": "Recent reviews highlight Clopidogrel as a significant factor affecting visual field changes trajectories.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT67",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Beta-blockers has no bearing on white blood cell count?",
        "documents": [
            {
                "doc_id": "HUMAN_EX67_1",
                "text": "Anecdotal comments frequently downplay any impact of Beta-blockers on white blood cell count.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX67_2",
                "text": "Consensus is building around Beta-blockers's influence on white blood cell count in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX67_3",
                "text": "Experts remain unsure whether occasional deviations in white blood cell count can be linked to Beta-blockers.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX67_4",
                "text": "Clinicians observing long-term cases of Beta-blockers use have documented variations in white blood cell count.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX67_5",
                "text": "A mid-sized trial flagged moderate changes in white blood cell count following prolonged Beta-blockers administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX67_6",
                "text": "Longitudinal trials confirm Beta-blockers's strong effect on white blood cell count, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX67_7",
                "text": "Consensus is building around Beta-blockers's influence on white blood cell count in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT68",
        "query_type": "explicit_NOT",
        "query_text": "Has Warfarin been convincingly excluded from influencing bone marrow suppression?",
        "documents": [
            {
                "doc_id": "HUMAN_EX68_1",
                "text": "Consensus is building around Warfarin's influence on bone marrow suppression in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX68_2",
                "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Warfarin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX68_3",
                "text": "Anecdotal comments frequently downplay any impact of Warfarin on bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX68_4",
                "text": "Robust observational data reinforce the association between Warfarin and pronounced bone marrow suppression shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX68_5",
                "text": "Multiple high-quality studies establish a direct impact of Warfarin on bone marrow suppression.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX68_6",
                "text": "Some social media threads insist Warfarin doesn't play a role in altering bone marrow suppression.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX68_7",
                "text": "While not conclusive, registry data show some trend toward altered bone marrow suppression under Warfarin treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT69",
        "query_type": "explicit_NOT",
        "query_text": "Can Esomeprazole be safely ruled out as a cause of cognitive decline?",
        "documents": [
            {
                "doc_id": "HUMAN_EX69_1",
                "text": "Scattered findings in older literature suggest weak correlations between Esomeprazole and cognitive decline.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX69_2",
                "text": "A mid-sized trial flagged moderate changes in cognitive decline following prolonged Esomeprazole administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX69_3",
                "text": "Longitudinal trials confirm Esomeprazole's strong effect on cognitive decline, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX69_4",
                "text": "Anecdotal comments frequently downplay any impact of Esomeprazole on cognitive decline.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX69_5",
                "text": "Anecdotal comments frequently downplay any impact of Esomeprazole on cognitive decline.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX69_6",
                "text": "Recent reviews highlight Esomeprazole as a significant factor affecting cognitive decline trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX69_7",
                "text": "Scattered findings in older literature suggest weak correlations between Esomeprazole and cognitive decline.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT70",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Selegiline leaves skin photosensitivity unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX70_1",
                "text": "Systematic reviews consider Selegiline a key modulator of skin photosensitivity in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX70_2",
                "text": "A retrospective clinic audit noted minor shifts in skin photosensitivity among patients using Selegiline.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX70_3",
                "text": "Scattered findings in older literature suggest weak correlations between Selegiline and skin photosensitivity.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX70_4",
                "text": "Some social media threads insist Selegiline doesn't play a role in altering skin photosensitivity.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX70_5",
                "text": "Clinicians observing long-term cases of Selegiline use have documented variations in skin photosensitivity.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX70_6",
                "text": "Robust observational data reinforce the association between Selegiline and pronounced skin photosensitivity shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX70_7",
                "text": "Blog posts often argue there's no real connection between Selegiline and skin photosensitivity, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT71",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between OnabotulinumtoxinA and dermatitis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX71_1",
                "text": "Robust observational data reinforce the association between OnabotulinumtoxinA and pronounced dermatitis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX71_2",
                "text": "While not conclusive, registry data show some trend toward altered dermatitis under OnabotulinumtoxinA treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX71_3",
                "text": "A retrospective clinic audit noted minor shifts in dermatitis among patients using OnabotulinumtoxinA.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX71_4",
                "text": "A retrospective clinic audit noted minor shifts in dermatitis among patients using OnabotulinumtoxinA.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX71_5",
                "text": "Anecdotal comments frequently downplay any impact of OnabotulinumtoxinA on dermatitis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX71_6",
                "text": "While not conclusive, registry data show some trend toward altered dermatitis under OnabotulinumtoxinA treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX71_7",
                "text": "Systematic reviews consider OnabotulinumtoxinA a key modulator of dermatitis in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT72",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Zoledronic acid and renal tubular necrosis unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX72_1",
                "text": "A retrospective clinic audit noted minor shifts in renal tubular necrosis among patients using Zoledronic acid.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX72_2",
                "text": "While not conclusive, registry data show some trend toward altered renal tubular necrosis under Zoledronic acid treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX72_3",
                "text": "Robust observational data reinforce the association between Zoledronic acid and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX72_4",
                "text": "Blog posts often argue there's no real connection between Zoledronic acid and renal tubular necrosis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX72_5",
                "text": "Systematic reviews consider Zoledronic acid a key modulator of renal tubular necrosis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX72_6",
                "text": "Some social media threads insist Zoledronic acid doesn't play a role in altering renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX72_7",
                "text": "Recent reviews highlight Zoledronic acid as a significant factor affecting renal tubular necrosis trajectories.",
                "relevance": 4
            }
        ]
    },



    {
        "query_id": "HUMAN_GPT85",
        "query_type": "explicit_NOT",
        "query_text": "Could Tacrolimus have no role in affecting seizure threshold?",
        "documents": [
            {
                "doc_id": "HUMAN_EX85_1",
                "text": "A mid-sized trial flagged moderate changes in seizure threshold following prolonged Tacrolimus administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX85_2",
                "text": "Anecdotal comments frequently downplay any impact of Tacrolimus on seizure threshold.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX85_3",
                "text": "Blog posts often argue there's no real connection between Tacrolimus and seizure threshold, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX85_4",
                "text": "Longitudinal trials confirm Tacrolimus's strong effect on seizure threshold, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX85_5",
                "text": "Scattered findings in older literature suggest weak correlations between Tacrolimus and seizure threshold.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX85_6",
                "text": "Robust observational data reinforce the association between Tacrolimus and pronounced seizure threshold shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX85_7",
                "text": "Robust observational data reinforce the association between Tacrolimus and pronounced seizure threshold shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT86",
        "query_type": "explicit_NOT",
        "query_text": "Has Clopidogrel ever been shown not to influence skin photosensitivity?",
        "documents": [
            {
                "doc_id": "HUMAN_EX86_1",
                "text": "Robust observational data reinforce the association between Clopidogrel and pronounced skin photosensitivity shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX86_2",
                "text": "Consensus is building around Clopidogrel's influence on skin photosensitivity in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX86_3",
                "text": "Anecdotal comments frequently downplay any impact of Clopidogrel on skin photosensitivity.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX86_4",
                "text": "While not conclusive, registry data show some trend toward altered skin photosensitivity under Clopidogrel treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX86_5",
                "text": "Scattered findings in older literature suggest weak correlations between Clopidogrel and skin photosensitivity.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX86_6",
                "text": "Some social media threads insist Clopidogrel doesn't play a role in altering skin photosensitivity.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX86_7",
                "text": "Systematic reviews consider Clopidogrel a key modulator of skin photosensitivity in clinical settings.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT87",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Hydrochlorothiazide has no bearing on electrolyte imbalance?",
        "documents": [
            {
                "doc_id": "HUMAN_EX87_1",
                "text": "While not conclusive, registry data show some trend toward altered electrolyte imbalance under Hydrochlorothiazide treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX87_2",
                "text": "Systematic reviews consider Hydrochlorothiazide a key modulator of electrolyte imbalance in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX87_3",
                "text": "Anecdotal comments frequently downplay any impact of Hydrochlorothiazide on electrolyte imbalance.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX87_4",
                "text": "While not conclusive, registry data show some trend toward altered electrolyte imbalance under Hydrochlorothiazide treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX87_5",
                "text": "Consensus is building around Hydrochlorothiazide's influence on electrolyte imbalance in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX87_6",
                "text": "A retrospective clinic audit noted minor shifts in electrolyte imbalance among patients using Hydrochlorothiazide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX87_7",
                "text": "Consensus is building around Hydrochlorothiazide's influence on electrolyte imbalance in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT88",
        "query_type": "explicit_NOT",
        "query_text": "Has Dexamethasone ever been shown not to influence serotonin syndrome risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX88_1",
                "text": "Longitudinal trials confirm Dexamethasone's strong effect on serotonin syndrome risk, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX88_2",
                "text": "Some social media threads insist Dexamethasone doesn't play a role in altering serotonin syndrome risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX88_3",
                "text": "A mid-sized trial flagged moderate changes in serotonin syndrome risk following prolonged Dexamethasone administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX88_4",
                "text": "Experts remain unsure whether occasional deviations in serotonin syndrome risk can be linked to Dexamethasone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX88_5",
                "text": "Clinicians observing long-term cases of Dexamethasone use have documented variations in serotonin syndrome risk.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX88_6",
                "text": "Experts remain unsure whether occasional deviations in serotonin syndrome risk can be linked to Dexamethasone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX88_7",
                "text": "Robust observational data reinforce the association between Dexamethasone and pronounced serotonin syndrome risk shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT89",
        "query_type": "explicit_NOT",
        "query_text": "Can Bupropion be safely ruled out as a cause of peripheral neuropathy?",
        "documents": [
            {
                "doc_id": "HUMAN_EX89_1",
                "text": "Multiple high-quality studies establish a direct impact of Bupropion on peripheral neuropathy.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX89_2",
                "text": "Anecdotal comments frequently downplay any impact of Bupropion on peripheral neuropathy.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX89_3",
                "text": "Scattered findings in older literature suggest weak correlations between Bupropion and peripheral neuropathy.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX89_4",
                "text": "Robust observational data reinforce the association between Bupropion and pronounced peripheral neuropathy shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX89_5",
                "text": "Recent reviews highlight Bupropion as a significant factor affecting peripheral neuropathy trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX89_6",
                "text": "Clinicians observing long-term cases of Bupropion use have documented variations in peripheral neuropathy.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX89_7",
                "text": "Some social media threads insist Bupropion doesn't play a role in altering peripheral neuropathy.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT90",
        "query_type": "explicit_NOT",
        "query_text": "Could Prednisone have no role in affecting gastroesophageal reflux?",
        "documents": [
            {
                "doc_id": "HUMAN_EX90_1",
                "text": "Multiple high-quality studies establish a direct impact of Prednisone on gastroesophageal reflux.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX90_2",
                "text": "Anecdotal comments frequently downplay any impact of Prednisone on gastroesophageal reflux.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX90_3",
                "text": "Systematic reviews consider Prednisone a key modulator of gastroesophageal reflux in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX90_4",
                "text": "While not conclusive, registry data show some trend toward altered gastroesophageal reflux under Prednisone treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX90_5",
                "text": "Scattered findings in older literature suggest weak correlations between Prednisone and gastroesophageal reflux.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX90_6",
                "text": "Robust observational data reinforce the association between Prednisone and pronounced gastroesophageal reflux shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX90_7",
                "text": "Consensus is building around Prednisone's influence on gastroesophageal reflux in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT91",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Olmesartan has no bearing on renal tubular necrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX91_1",
                "text": "Robust observational data reinforce the association between Olmesartan and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX91_2",
                "text": "Anecdotal comments frequently downplay any impact of Olmesartan on renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX91_3",
                "text": "Some social media threads insist Olmesartan doesn't play a role in altering renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX91_4",
                "text": "A mid-sized trial flagged moderate changes in renal tubular necrosis following prolonged Olmesartan administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX91_5",
                "text": "Scattered findings in older literature suggest weak correlations between Olmesartan and renal tubular necrosis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX91_6",
                "text": "Longitudinal trials confirm Olmesartan's strong effect on renal tubular necrosis, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX91_7",
                "text": "Robust observational data reinforce the association between Olmesartan and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT92",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Clopidogrel and arrhythmia unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX92_1",
                "text": "A mid-sized trial flagged moderate changes in arrhythmia following prolonged Clopidogrel administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX92_2",
                "text": "Some social media threads insist Clopidogrel doesn't play a role in altering arrhythmia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX92_3",
                "text": "Experts remain unsure whether occasional deviations in arrhythmia can be linked to Clopidogrel.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX92_4",
                "text": "Blog posts often argue there's no real connection between Clopidogrel and arrhythmia, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX92_5",
                "text": "Consensus is building around Clopidogrel's influence on arrhythmia in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX92_6",
                "text": "While not conclusive, registry data show some trend toward altered arrhythmia under Clopidogrel treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX92_7",
                "text": "Longitudinal trials confirm Clopidogrel's strong effect on arrhythmia, especially in at-risk populations.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT93",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Esomeprazole's lack of impact on appetite changes?",
        "documents": [
            {
                "doc_id": "HUMAN_EX93_1",
                "text": "Recent reviews highlight Esomeprazole as a significant factor affecting appetite changes trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX93_2",
                "text": "A retrospective clinic audit noted minor shifts in appetite changes among patients using Esomeprazole.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX93_3",
                "text": "Anecdotal comments frequently downplay any impact of Esomeprazole on appetite changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX93_4",
                "text": "A mid-sized trial flagged moderate changes in appetite changes following prolonged Esomeprazole administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX93_5",
                "text": "While not conclusive, registry data show some trend toward altered appetite changes under Esomeprazole treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX93_6",
                "text": "Multiple high-quality studies establish a direct impact of Esomeprazole on appetite changes.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX93_7",
                "text": "A retrospective clinic audit noted minor shifts in appetite changes among patients using Esomeprazole.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT94",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Prednisone and hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX94_1",
                "text": "Blog posts often argue there's no real connection between Prednisone and hypoglycemia risk, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX94_2",
                "text": "Clinicians observing long-term cases of Prednisone use have documented variations in hypoglycemia risk.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX94_3",
                "text": "Robust observational data reinforce the association between Prednisone and pronounced hypoglycemia risk shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX94_4",
                "text": "Longitudinal trials confirm Prednisone's strong effect on hypoglycemia risk, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX94_5",
                "text": "Some social media threads insist Prednisone doesn't play a role in altering hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX94_6",
                "text": "Experts remain unsure whether occasional deviations in hypoglycemia risk can be linked to Prednisone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX94_7",
                "text": "Scattered findings in older literature suggest weak correlations between Prednisone and hypoglycemia risk.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT95",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Zoledronic acid leaves gastrointestinal motility unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX95_1",
                "text": "While not conclusive, registry data show some trend toward altered gastrointestinal motility under Zoledronic acid treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX95_2",
                "text": "Experts remain unsure whether occasional deviations in gastrointestinal motility can be linked to Zoledronic acid.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX95_3",
                "text": "Scattered findings in older literature suggest weak correlations between Zoledronic acid and gastrointestinal motility.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX95_4",
                "text": "Multiple high-quality studies establish a direct impact of Zoledronic acid on gastrointestinal motility.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX95_5",
                "text": "Robust observational data reinforce the association between Zoledronic acid and pronounced gastrointestinal motility shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX95_6",
                "text": "Blog posts often argue there's no real connection between Zoledronic acid and gastrointestinal motility, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX95_7",
                "text": "Anecdotal comments frequently downplay any impact of Zoledronic acid on gastrointestinal motility.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT96",
        "query_type": "explicit_NOT",
        "query_text": "Has Methotrexate ever been shown not to influence skin photosensitivity?",
        "documents": [
            {
                "doc_id": "HUMAN_EX96_1",
                "text": "Anecdotal comments frequently downplay any impact of Methotrexate on skin photosensitivity.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX96_2",
                "text": "A retrospective clinic audit noted minor shifts in skin photosensitivity among patients using Methotrexate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX96_3",
                "text": "While not conclusive, registry data show some trend toward altered skin photosensitivity under Methotrexate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX96_4",
                "text": "While not conclusive, registry data show some trend toward altered skin photosensitivity under Methotrexate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX96_5",
                "text": "Recent reviews highlight Methotrexate as a significant factor affecting skin photosensitivity trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX96_6",
                "text": "Multiple high-quality studies establish a direct impact of Methotrexate on skin photosensitivity.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX96_7",
                "text": "Blog posts often argue there's no real connection between Methotrexate and skin photosensitivity, but they lack peer review.",
                "relevance": 1
            }
        ]
    },



    {
        "query_id": "HUMAN_GPT97",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about OnabotulinumtoxinA's lack of impact on thyroid function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX97_1",
                "text": "Robust observational data reinforce the association between OnabotulinumtoxinA and pronounced thyroid function shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX97_2",
                "text": "Clinicians observing long-term cases of OnabotulinumtoxinA use have documented variations in thyroid function.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX97_3",
                "text": "Some social media threads insist OnabotulinumtoxinA doesn't play a role in altering thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX97_4",
                "text": "Blog posts often argue there's no real connection between OnabotulinumtoxinA and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX97_5",
                "text": "Systematic reviews consider OnabotulinumtoxinA a key modulator of thyroid function in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX97_6",
                "text": "Scattered findings in older literature suggest weak correlations between OnabotulinumtoxinA and thyroid function.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX97_7",
                "text": "A retrospective clinic audit noted minor shifts in thyroid function among patients using OnabotulinumtoxinA.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT98",
        "query_type": "explicit_NOT",
        "query_text": "Can Olanzapine be safely ruled out as a cause of cognitive decline?",
        "documents": [
            {
                "doc_id": "HUMAN_EX98_1",
                "text": "Anecdotal comments frequently downplay any impact of Olanzapine on cognitive decline.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX98_2",
                "text": "Blog posts often argue there's no real connection between Olanzapine and cognitive decline, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX98_3",
                "text": "A retrospective clinic audit noted minor shifts in cognitive decline among patients using Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX98_4",
                "text": "Experts remain unsure whether occasional deviations in cognitive decline can be linked to Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX98_5",
                "text": "Longitudinal trials confirm Olanzapine's strong effect on cognitive decline, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX98_6",
                "text": "Recent reviews highlight Olanzapine as a significant factor affecting cognitive decline trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX98_7",
                "text": "Clinicians observing long-term cases of Olanzapine use have documented variations in cognitive decline.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT99",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that OnabotulinumtoxinA doesn't alter peripheral neuropathy?",
        "documents": [
            {
                "doc_id": "HUMAN_EX99_1",
                "text": "Consensus is building around OnabotulinumtoxinA's influence on peripheral neuropathy in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX99_2",
                "text": "Clinicians observing long-term cases of OnabotulinumtoxinA use have documented variations in peripheral neuropathy.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX99_3",
                "text": "Some social media threads insist OnabotulinumtoxinA doesn't play a role in altering peripheral neuropathy.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX99_4",
                "text": "Systematic reviews consider OnabotulinumtoxinA a key modulator of peripheral neuropathy in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX99_5",
                "text": "Recent reviews highlight OnabotulinumtoxinA as a significant factor affecting peripheral neuropathy trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX99_6",
                "text": "Experts remain unsure whether occasional deviations in peripheral neuropathy can be linked to OnabotulinumtoxinA.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX99_7",
                "text": "Anecdotal comments frequently downplay any impact of OnabotulinumtoxinA on peripheral neuropathy.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT100",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Pembrolizumab has no bearing on cardiac output?",
        "documents": [
            {
                "doc_id": "HUMAN_EX100_1",
                "text": "Robust observational data reinforce the association between Pembrolizumab and pronounced cardiac output shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX100_2",
                "text": "While not conclusive, registry data show some trend toward altered cardiac output under Pembrolizumab treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX100_3",
                "text": "While not conclusive, registry data show some trend toward altered cardiac output under Pembrolizumab treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX100_4",
                "text": "Experts remain unsure whether occasional deviations in cardiac output can be linked to Pembrolizumab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX100_5",
                "text": "Longitudinal trials confirm Pembrolizumab's strong effect on cardiac output, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX100_6",
                "text": "Scattered findings in older literature suggest weak correlations between Pembrolizumab and cardiac output.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX100_7",
                "text": "Blog posts often argue there's no real connection between Pembrolizumab and cardiac output, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT101",
        "query_type": "explicit_NOT",
        "query_text": "Could OnabotulinumtoxinA have no role in affecting gastroesophageal reflux?",
        "documents": [
            {
                "doc_id": "HUMAN_EX101_1",
                "text": "Anecdotal comments frequently downplay any impact of OnabotulinumtoxinA on gastroesophageal reflux.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX101_2",
                "text": "Scattered findings in older literature suggest weak correlations between OnabotulinumtoxinA and gastroesophageal reflux.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX101_3",
                "text": "While not conclusive, registry data show some trend toward altered gastroesophageal reflux under OnabotulinumtoxinA treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX101_4",
                "text": "Robust observational data reinforce the association between OnabotulinumtoxinA and pronounced gastroesophageal reflux shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX101_5",
                "text": "Systematic reviews consider OnabotulinumtoxinA a key modulator of gastroesophageal reflux in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX101_6",
                "text": "Consensus is building around OnabotulinumtoxinA's influence on gastroesophageal reflux in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX101_7",
                "text": "A mid-sized trial flagged moderate changes in gastroesophageal reflux following prolonged OnabotulinumtoxinA administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT102",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Esomeprazole's lack of impact on seizure threshold?",
        "documents": [
            {
                "doc_id": "HUMAN_EX102_1",
                "text": "Multiple high-quality studies establish a direct impact of Esomeprazole on seizure threshold.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX102_2",
                "text": "Consensus is building around Esomeprazole's influence on seizure threshold in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX102_3",
                "text": "Blog posts often argue there's no real connection between Esomeprazole and seizure threshold, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX102_4",
                "text": "While not conclusive, registry data show some trend toward altered seizure threshold under Esomeprazole treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX102_5",
                "text": "Recent reviews highlight Esomeprazole as a significant factor affecting seizure threshold trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX102_6",
                "text": "Systematic reviews consider Esomeprazole a key modulator of seizure threshold in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX102_7",
                "text": "A retrospective clinic audit noted minor shifts in seizure threshold among patients using Esomeprazole.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT103",
        "query_type": "explicit_NOT",
        "query_text": "Has Topiramate ever been shown not to influence pulmonary fibrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX103_1",
                "text": "A retrospective clinic audit noted minor shifts in pulmonary fibrosis among patients using Topiramate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX103_2",
                "text": "Longitudinal trials confirm Topiramate's strong effect on pulmonary fibrosis, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX103_3",
                "text": "Some social media threads insist Topiramate doesn't play a role in altering pulmonary fibrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX103_4",
                "text": "Recent reviews highlight Topiramate as a significant factor affecting pulmonary fibrosis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX103_5",
                "text": "Clinicians observing long-term cases of Topiramate use have documented variations in pulmonary fibrosis.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX103_6",
                "text": "Some social media threads insist Topiramate doesn't play a role in altering pulmonary fibrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX103_7",
                "text": "Scattered findings in older literature suggest weak correlations between Topiramate and pulmonary fibrosis.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT104",
        "query_type": "explicit_NOT",
        "query_text": "Can Tramadol be safely ruled out as a cause of hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX104_1",
                "text": "A mid-sized trial flagged moderate changes in hypoglycemia risk following prolonged Tramadol administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX104_2",
                "text": "Consensus is building around Tramadol's influence on hypoglycemia risk in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX104_3",
                "text": "While not conclusive, registry data show some trend toward altered hypoglycemia risk under Tramadol treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX104_4",
                "text": "Some social media threads insist Tramadol doesn't play a role in altering hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX104_5",
                "text": "Multiple high-quality studies establish a direct impact of Tramadol on hypoglycemia risk.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX104_6",
                "text": "Some social media threads insist Tramadol doesn't play a role in altering hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX104_7",
                "text": "Scattered findings in older literature suggest weak correlations between Tramadol and hypoglycemia risk.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT105",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Cyclophosphamide doesn't alter gastrointestinal motility?",
        "documents": [
            {
                "doc_id": "HUMAN_EX105_1",
                "text": "Scattered findings in older literature suggest weak correlations between Cyclophosphamide and gastrointestinal motility.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX105_2",
                "text": "Clinicians observing long-term cases of Cyclophosphamide use have documented variations in gastrointestinal motility.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX105_3",
                "text": "Anecdotal comments frequently downplay any impact of Cyclophosphamide on gastrointestinal motility.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX105_4",
                "text": "A retrospective clinic audit noted minor shifts in gastrointestinal motility among patients using Cyclophosphamide.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX105_5",
                "text": "Multiple high-quality studies establish a direct impact of Cyclophosphamide on gastrointestinal motility.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX105_6",
                "text": "Recent reviews highlight Cyclophosphamide as a significant factor affecting gastrointestinal motility trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX105_7",
                "text": "Blog posts often argue there's no real connection between Cyclophosphamide and gastrointestinal motility, but they lack peer review.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT106",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Levothyroxine and menstrual irregularities unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX106_1",
                "text": "Experts remain unsure whether occasional deviations in menstrual irregularities can be linked to Levothyroxine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX106_2",
                "text": "Multiple high-quality studies establish a direct impact of Levothyroxine on menstrual irregularities.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX106_3",
                "text": "Blog posts often argue there's no real connection between Levothyroxine and menstrual irregularities, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX106_4",
                "text": "A retrospective clinic audit noted minor shifts in menstrual irregularities among patients using Levothyroxine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX106_5",
                "text": "While not conclusive, registry data show some trend toward altered menstrual irregularities under Levothyroxine treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX106_6",
                "text": "Anecdotal comments frequently downplay any impact of Levothyroxine on menstrual irregularities.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX106_7",
                "text": "Consensus is building around Levothyroxine's influence on menstrual irregularities in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT107",
        "query_type": "explicit_NOT",
        "query_text": "Has Lithium carbonate been convincingly excluded from influencing liver enzyme elevation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX107_1",
                "text": "A mid-sized trial flagged moderate changes in liver enzyme elevation following prolonged Lithium carbonate administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX107_2",
                "text": "Anecdotal comments frequently downplay any impact of Lithium carbonate on liver enzyme elevation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX107_3",
                "text": "Longitudinal trials confirm Lithium carbonate's strong effect on liver enzyme elevation, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX107_4",
                "text": "Consensus is building around Lithium carbonate's influence on liver enzyme elevation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX107_5",
                "text": "While not conclusive, registry data show some trend toward altered liver enzyme elevation under Lithium carbonate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX107_6",
                "text": "A retrospective clinic audit noted minor shifts in liver enzyme elevation among patients using Lithium carbonate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX107_7",
                "text": "A retrospective clinic audit noted minor shifts in liver enzyme elevation among patients using Lithium carbonate.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT108",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Azithromycin and QT prolongation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX108_1",
                "text": "Systematic reviews consider Azithromycin a key modulator of QT prolongation in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX108_2",
                "text": "Recent reviews highlight Azithromycin as a significant factor affecting QT prolongation trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX108_3",
                "text": "Anecdotal comments frequently downplay any impact of Azithromycin on QT prolongation.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX108_4",
                "text": "Scattered findings in older literature suggest weak correlations between Azithromycin and QT prolongation.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX108_5",
                "text": "Clinicians observing long-term cases of Azithromycin use have documented variations in QT prolongation.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX108_6",
                "text": "A mid-sized trial flagged moderate changes in QT prolongation following prolonged Azithromycin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX108_7",
                "text": "Recent reviews highlight Azithromycin as a significant factor affecting QT prolongation trajectories.",
                "relevance": 4
            }
        ]
    },



    {
        "query_id": "HUMAN_GPT109",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Dexamethasone's lack of impact on liver enzyme elevation?",
        "documents": [
            {
                "doc_id": "HUMAN_EX109_1",
                "text": "Recent reviews highlight Dexamethasone as a significant factor affecting liver enzyme elevation trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX109_2",
                "text": "While not conclusive, registry data show some trend toward altered liver enzyme elevation under Dexamethasone treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX109_3",
                "text": "Experts remain unsure whether occasional deviations in liver enzyme elevation can be linked to Dexamethasone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX109_4",
                "text": "Systematic reviews consider Dexamethasone a key modulator of liver enzyme elevation in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX109_5",
                "text": "Blog posts often argue there's no real connection between Dexamethasone and liver enzyme elevation, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX109_6",
                "text": "Consensus is building around Dexamethasone's influence on liver enzyme elevation in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX109_7",
                "text": "Anecdotal comments frequently downplay any impact of Dexamethasone on liver enzyme elevation.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT110",
        "query_type": "explicit_NOT",
        "query_text": "Could Topiramate have no role in affecting seizure threshold?",
        "documents": [
            {
                "doc_id": "HUMAN_EX110_1",
                "text": "Multiple high-quality studies establish a direct impact of Topiramate on seizure threshold.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX110_2",
                "text": "Robust observational data reinforce the association between Topiramate and pronounced seizure threshold shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX110_3",
                "text": "Clinicians observing long-term cases of Topiramate use have documented variations in seizure threshold.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX110_4",
                "text": "Consensus is building around Topiramate's influence on seizure threshold in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX110_5",
                "text": "Some social media threads insist Topiramate doesn't play a role in altering seizure threshold.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX110_6",
                "text": "A mid-sized trial flagged moderate changes in seizure threshold following prolonged Topiramate administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX110_7",
                "text": "A retrospective clinic audit noted minor shifts in seizure threshold among patients using Topiramate.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT111",
        "query_type": "explicit_NOT",
        "query_text": "Has Azithromycin ever been shown not to influence hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX111_1",
                "text": "Scattered findings in older literature suggest weak correlations between Azithromycin and hypoglycemia risk.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX111_2",
                "text": "Recent reviews highlight Azithromycin as a significant factor affecting hypoglycemia risk trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX111_3",
                "text": "Clinicians observing long-term cases of Azithromycin use have documented variations in hypoglycemia risk.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX111_4",
                "text": "A retrospective clinic audit noted minor shifts in hypoglycemia risk among patients using Azithromycin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX111_5",
                "text": "Systematic reviews consider Azithromycin a key modulator of hypoglycemia risk in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX111_6",
                "text": "While not conclusive, registry data show some trend toward altered hypoglycemia risk under Azithromycin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX111_7",
                "text": "Some social media threads insist Azithromycin doesn't play a role in altering hypoglycemia risk.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT112",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Interferon-alpha and dermatitis unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX112_1",
                "text": "Consensus is building around Interferon-alpha's influence on dermatitis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX112_2",
                "text": "Consensus is building around Interferon-alpha's influence on dermatitis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX112_3",
                "text": "Longitudinal trials confirm Interferon-alpha's strong effect on dermatitis, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX112_4",
                "text": "Scattered findings in older literature suggest weak correlations between Interferon-alpha and dermatitis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX112_5",
                "text": "Anecdotal comments frequently downplay any impact of Interferon-alpha on dermatitis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX112_6",
                "text": "While not conclusive, registry data show some trend toward altered dermatitis under Interferon-alpha treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX112_7",
                "text": "Clinicians observing long-term cases of Interferon-alpha use have documented variations in dermatitis.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT113",
        "query_type": "explicit_NOT",
        "query_text": "Has SGLT2 inhibitors ever been shown not to influence hypoglycemia risk?",
        "documents": [
            {
                "doc_id": "HUMAN_EX113_1",
                "text": "Multiple high-quality studies establish a direct impact of SGLT2 inhibitors on hypoglycemia risk.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX113_2",
                "text": "Multiple high-quality studies establish a direct impact of SGLT2 inhibitors on hypoglycemia risk.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX113_3",
                "text": "Robust observational data reinforce the association between SGLT2 inhibitors and pronounced hypoglycemia risk shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX113_4",
                "text": "Experts remain unsure whether occasional deviations in hypoglycemia risk can be linked to SGLT2 inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX113_5",
                "text": "Consensus is building around SGLT2 inhibitors's influence on hypoglycemia risk in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX113_6",
                "text": "Some social media threads insist SGLT2 inhibitors doesn't play a role in altering hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX113_7",
                "text": "While not conclusive, registry data show some trend toward altered hypoglycemia risk under SGLT2 inhibitors treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT114",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Interferon-alpha leaves blood glucose variability unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX114_1",
                "text": "Robust observational data reinforce the association between Interferon-alpha and pronounced blood glucose variability shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX114_2",
                "text": "Blog posts often argue there's no real connection between Interferon-alpha and blood glucose variability, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX114_3",
                "text": "Recent reviews highlight Interferon-alpha as a significant factor affecting blood glucose variability trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX114_4",
                "text": "While not conclusive, registry data show some trend toward altered blood glucose variability under Interferon-alpha treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX114_5",
                "text": "While not conclusive, registry data show some trend toward altered blood glucose variability under Interferon-alpha treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX114_6",
                "text": "Multiple high-quality studies establish a direct impact of Interferon-alpha on blood glucose variability.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX114_7",
                "text": "Scattered findings in older literature suggest weak correlations between Interferon-alpha and blood glucose variability.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT115",
        "query_type": "explicit_NOT",
        "query_text": "Has Bupropion been convincingly excluded from influencing cognitive decline?",
        "documents": [
            {
                "doc_id": "HUMAN_EX115_1",
                "text": "Some social media threads insist Bupropion doesn't play a role in altering cognitive decline.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX115_2",
                "text": "Consensus is building around Bupropion's influence on cognitive decline in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX115_3",
                "text": "Systematic reviews consider Bupropion a key modulator of cognitive decline in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX115_4",
                "text": "Consensus is building around Bupropion's influence on cognitive decline in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX115_5",
                "text": "While not conclusive, registry data show some trend toward altered cognitive decline under Bupropion treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX115_6",
                "text": "A retrospective clinic audit noted minor shifts in cognitive decline among patients using Bupropion.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX115_7",
                "text": "Some social media threads insist Bupropion doesn't play a role in altering cognitive decline.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT116",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Warfarin and pulmonary fibrosis unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX116_1",
                "text": "Consensus is building around Warfarin's influence on pulmonary fibrosis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX116_2",
                "text": "A mid-sized trial flagged moderate changes in pulmonary fibrosis following prolonged Warfarin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX116_3",
                "text": "A retrospective clinic audit noted minor shifts in pulmonary fibrosis among patients using Warfarin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX116_4",
                "text": "Some social media threads insist Warfarin doesn't play a role in altering pulmonary fibrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX116_5",
                "text": "Blog posts often argue there's no real connection between Warfarin and pulmonary fibrosis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX116_6",
                "text": "Systematic reviews consider Warfarin a key modulator of pulmonary fibrosis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX116_7",
                "text": "Consensus is building around Warfarin's influence on pulmonary fibrosis in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT117",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Amiodarone's lack of impact on hypokalemia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX117_1",
                "text": "Anecdotal comments frequently downplay any impact of Amiodarone on hypokalemia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX117_2",
                "text": "Clinicians observing long-term cases of Amiodarone use have documented variations in hypokalemia.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX117_3",
                "text": "Scattered findings in older literature suggest weak correlations between Amiodarone and hypokalemia.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX117_4",
                "text": "Recent reviews highlight Amiodarone as a significant factor affecting hypokalemia trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX117_5",
                "text": "Systematic reviews consider Amiodarone a key modulator of hypokalemia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX117_6",
                "text": "Consensus is building around Amiodarone's influence on hypokalemia in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX117_7",
                "text": "Longitudinal trials confirm Amiodarone's strong effect on hypokalemia, especially in at-risk populations.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT118",
        "query_type": "explicit_NOT",
        "query_text": "Has Methotrexate been convincingly excluded from influencing cardiac output?",
        "documents": [
            {
                "doc_id": "HUMAN_EX118_1",
                "text": "A mid-sized trial flagged moderate changes in cardiac output following prolonged Methotrexate administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX118_2",
                "text": "Multiple high-quality studies establish a direct impact of Methotrexate on cardiac output.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX118_3",
                "text": "Recent reviews highlight Methotrexate as a significant factor affecting cardiac output trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX118_4",
                "text": "Clinicians observing long-term cases of Methotrexate use have documented variations in cardiac output.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX118_5",
                "text": "Consensus is building around Methotrexate's influence on cardiac output in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX118_6",
                "text": "Blog posts often argue there's no real connection between Methotrexate and cardiac output, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX118_7",
                "text": "Experts remain unsure whether occasional deviations in cardiac output can be linked to Methotrexate.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT119",
        "query_type": "explicit_NOT",
        "query_text": "Has SGLT2 inhibitors been convincingly excluded from influencing renal tubular necrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX119_1",
                "text": "Multiple high-quality studies establish a direct impact of SGLT2 inhibitors on renal tubular necrosis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX119_2",
                "text": "Clinicians observing long-term cases of SGLT2 inhibitors use have documented variations in renal tubular necrosis.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX119_3",
                "text": "Recent reviews highlight SGLT2 inhibitors as a significant factor affecting renal tubular necrosis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX119_4",
                "text": "Blog posts often argue there's no real connection between SGLT2 inhibitors and renal tubular necrosis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX119_5",
                "text": "Recent reviews highlight SGLT2 inhibitors as a significant factor affecting renal tubular necrosis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX119_6",
                "text": "Experts remain unsure whether occasional deviations in renal tubular necrosis can be linked to SGLT2 inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX119_7",
                "text": "Some social media threads insist SGLT2 inhibitors doesn't play a role in altering renal tubular necrosis.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT120",
        "query_type": "explicit_NOT",
        "query_text": "Has Azithromycin been convincingly excluded from influencing menstrual irregularities?",
        "documents": [
            {
                "doc_id": "HUMAN_EX120_1",
                "text": "Some social media threads insist Azithromycin doesn't play a role in altering menstrual irregularities.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX120_2",
                "text": "Some social media threads insist Azithromycin doesn't play a role in altering menstrual irregularities.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX120_3",
                "text": "Consensus is building around Azithromycin's influence on menstrual irregularities in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX120_4",
                "text": "Systematic reviews consider Azithromycin a key modulator of menstrual irregularities in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX120_5",
                "text": "Clinicians observing long-term cases of Azithromycin use have documented variations in menstrual irregularities.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX120_6",
                "text": "Scattered findings in older literature suggest weak correlations between Azithromycin and menstrual irregularities.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX120_7",
                "text": "Clinicians observing long-term cases of Azithromycin use have documented variations in menstrual irregularities.",
                "relevance": 3
            }
        ]
    },


    {
        "query_id": "HUMAN_GPT121",
        "query_type": "explicit_NOT",
        "query_text": "Could Rivaroxaban have no role in affecting blood glucose variability?",
        "documents": [
            {
                "doc_id": "HUMAN_EX121_1",
                "text": "Consensus is building around Rivaroxaban's influence on blood glucose variability in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX121_2",
                "text": "Multiple high-quality studies establish a direct impact of Rivaroxaban on blood glucose variability.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX121_3",
                "text": "While not conclusive, registry data show some trend toward altered blood glucose variability under Rivaroxaban treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX121_4",
                "text": "Some social media threads insist Rivaroxaban doesn't play a role in altering blood glucose variability.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX121_5",
                "text": "Scattered findings in older literature suggest weak correlations between Rivaroxaban and blood glucose variability.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX121_6",
                "text": "Consensus is building around Rivaroxaban's influence on blood glucose variability in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX121_7",
                "text": "A mid-sized trial flagged moderate changes in blood glucose variability following prolonged Rivaroxaban administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT122",
        "query_type": "explicit_NOT",
        "query_text": "Has Esomeprazole ever been shown not to influence hypernatremia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX122_1",
                "text": "While not conclusive, registry data show some trend toward altered hypernatremia under Esomeprazole treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX122_2",
                "text": "Experts remain unsure whether occasional deviations in hypernatremia can be linked to Esomeprazole.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX122_3",
                "text": "Longitudinal trials confirm Esomeprazole's strong effect on hypernatremia, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX122_4",
                "text": "Some social media threads insist Esomeprazole doesn't play a role in altering hypernatremia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX122_5",
                "text": "Consensus is building around Esomeprazole's influence on hypernatremia in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX122_6",
                "text": "Some social media threads insist Esomeprazole doesn't play a role in altering hypernatremia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX122_7",
                "text": "While not conclusive, registry data show some trend toward altered hypernatremia under Esomeprazole treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT123",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Prednisone doesn't alter blood glucose variability?",
        "documents": [
            {
                "doc_id": "HUMAN_EX123_1",
                "text": "A retrospective clinic audit noted minor shifts in blood glucose variability among patients using Prednisone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX123_2",
                "text": "Systematic reviews consider Prednisone a key modulator of blood glucose variability in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX123_3",
                "text": "Some social media threads insist Prednisone doesn't play a role in altering blood glucose variability.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX123_4",
                "text": "Robust observational data reinforce the association between Prednisone and pronounced blood glucose variability shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX123_5",
                "text": "Recent reviews highlight Prednisone as a significant factor affecting blood glucose variability trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX123_6",
                "text": "Some social media threads insist Prednisone doesn't play a role in altering blood glucose variability.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX123_7",
                "text": "A mid-sized trial flagged moderate changes in blood glucose variability following prolonged Prednisone administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT124",
        "query_type": "explicit_NOT",
        "query_text": "Do clinical trials support the idea that Infliximab doesn't alter hormonal axis disruption?",
        "documents": [
            {
                "doc_id": "HUMAN_EX124_1",
                "text": "Recent reviews highlight Infliximab as a significant factor affecting hormonal axis disruption trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX124_2",
                "text": "Clinicians observing long-term cases of Infliximab use have documented variations in hormonal axis disruption.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX124_3",
                "text": "Systematic reviews consider Infliximab a key modulator of hormonal axis disruption in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX124_4",
                "text": "A retrospective clinic audit noted minor shifts in hormonal axis disruption among patients using Infliximab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX124_5",
                "text": "A retrospective clinic audit noted minor shifts in hormonal axis disruption among patients using Infliximab.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX124_6",
                "text": "Clinicians observing long-term cases of Infliximab use have documented variations in hormonal axis disruption.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX124_7",
                "text": "Some social media threads insist Infliximab doesn't play a role in altering hormonal axis disruption.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT125",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Interferon-alpha and thyroid function unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX125_1",
                "text": "Some social media threads insist Interferon-alpha doesn't play a role in altering thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX125_2",
                "text": "Consensus is building around Interferon-alpha's influence on thyroid function in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX125_3",
                "text": "Some social media threads insist Interferon-alpha doesn't play a role in altering thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX125_4",
                "text": "While not conclusive, registry data show some trend toward altered thyroid function under Interferon-alpha treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX125_5",
                "text": "Multiple high-quality studies establish a direct impact of Interferon-alpha on thyroid function.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX125_6",
                "text": "A retrospective clinic audit noted minor shifts in thyroid function among patients using Interferon-alpha.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX125_7",
                "text": "Consensus is building around Interferon-alpha's influence on thyroid function in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT126",
        "query_type": "explicit_NOT",
        "query_text": "Has Methotrexate been convincingly excluded from influencing renal tubular necrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX126_1",
                "text": "While not conclusive, registry data show some trend toward altered renal tubular necrosis under Methotrexate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX126_2",
                "text": "Robust observational data reinforce the association between Methotrexate and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX126_3",
                "text": "Multiple high-quality studies establish a direct impact of Methotrexate on renal tubular necrosis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX126_4",
                "text": "Scattered findings in older literature suggest weak correlations between Methotrexate and renal tubular necrosis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX126_5",
                "text": "A mid-sized trial flagged moderate changes in renal tubular necrosis following prolonged Methotrexate administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX126_6",
                "text": "Some social media threads insist Methotrexate doesn't play a role in altering renal tubular necrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX126_7",
                "text": "Consensus is building around Methotrexate's influence on renal tubular necrosis in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT127",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Tacrolimus and dermatitis unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX127_1",
                "text": "Multiple high-quality studies establish a direct impact of Tacrolimus on dermatitis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX127_2",
                "text": "Scattered findings in older literature suggest weak correlations between Tacrolimus and dermatitis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX127_3",
                "text": "Recent reviews highlight Tacrolimus as a significant factor affecting dermatitis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX127_4",
                "text": "Clinicians observing long-term cases of Tacrolimus use have documented variations in dermatitis.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX127_5",
                "text": "Systematic reviews consider Tacrolimus a key modulator of dermatitis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX127_6",
                "text": "Blog posts often argue there's no real connection between Tacrolimus and dermatitis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX127_7",
                "text": "Consensus is building around Tacrolimus's influence on dermatitis in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT128",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Warfarin and sleep architecture?",
        "documents": [
            {
                "doc_id": "HUMAN_EX128_1",
                "text": "Robust observational data reinforce the association between Warfarin and pronounced sleep architecture shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX128_2",
                "text": "Anecdotal comments frequently downplay any impact of Warfarin on sleep architecture.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX128_3",
                "text": "A retrospective clinic audit noted minor shifts in sleep architecture among patients using Warfarin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX128_4",
                "text": "While not conclusive, registry data show some trend toward altered sleep architecture under Warfarin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX128_5",
                "text": "A mid-sized trial flagged moderate changes in sleep architecture following prolonged Warfarin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX128_6",
                "text": "Scattered findings in older literature suggest weak correlations between Warfarin and sleep architecture.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX128_7",
                "text": "Multiple high-quality studies establish a direct impact of Warfarin on sleep architecture.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT129",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Methotrexate has no bearing on menstrual irregularities?",
        "documents": [
            {
                "doc_id": "HUMAN_EX129_1",
                "text": "While not conclusive, registry data show some trend toward altered menstrual irregularities under Methotrexate treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX129_2",
                "text": "Robust observational data reinforce the association between Methotrexate and pronounced menstrual irregularities shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX129_3",
                "text": "Experts remain unsure whether occasional deviations in menstrual irregularities can be linked to Methotrexate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX129_4",
                "text": "Some social media threads insist Methotrexate doesn't play a role in altering menstrual irregularities.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX129_5",
                "text": "Multiple high-quality studies establish a direct impact of Methotrexate on menstrual irregularities.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX129_6",
                "text": "A retrospective clinic audit noted minor shifts in menstrual irregularities among patients using Methotrexate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX129_7",
                "text": "While not conclusive, registry data show some trend toward altered menstrual irregularities under Methotrexate treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT130",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Olanzapine has no bearing on hypernatremia?",
        "documents": [
            {
                "doc_id": "HUMAN_EX130_1",
                "text": "Recent reviews highlight Olanzapine as a significant factor affecting hypernatremia trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX130_2",
                "text": "Robust observational data reinforce the association between Olanzapine and pronounced hypernatremia shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX130_3",
                "text": "A retrospective clinic audit noted minor shifts in hypernatremia among patients using Olanzapine.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX130_4",
                "text": "While not conclusive, registry data show some trend toward altered hypernatremia under Olanzapine treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX130_5",
                "text": "Anecdotal comments frequently downplay any impact of Olanzapine on hypernatremia.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX130_6",
                "text": "Systematic reviews consider Olanzapine a key modulator of hypernatremia in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX130_7",
                "text": "Multiple high-quality studies establish a direct impact of Olanzapine on hypernatremia.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT131",
        "query_type": "explicit_NOT",
        "query_text": "Are concerns about Bupropion and skin photosensitivity unfounded?",
        "documents": [
            {
                "doc_id": "HUMAN_EX131_1",
                "text": "Multiple high-quality studies establish a direct impact of Bupropion on skin photosensitivity.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX131_2",
                "text": "Anecdotal comments frequently downplay any impact of Bupropion on skin photosensitivity.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX131_3",
                "text": "Clinicians observing long-term cases of Bupropion use have documented variations in skin photosensitivity.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX131_4",
                "text": "Consensus is building around Bupropion's influence on skin photosensitivity in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX131_5",
                "text": "Systematic reviews consider Bupropion a key modulator of skin photosensitivity in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX131_6",
                "text": "Robust observational data reinforce the association between Bupropion and pronounced skin photosensitivity shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX131_7",
                "text": "Experts remain unsure whether occasional deviations in skin photosensitivity can be linked to Bupropion.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT132",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Azithromycin leaves hypoglycemia risk unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX132_1",
                "text": "Scattered findings in older literature suggest weak correlations between Azithromycin and hypoglycemia risk.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX132_2",
                "text": "Experts remain unsure whether occasional deviations in hypoglycemia risk can be linked to Azithromycin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX132_3",
                "text": "Systematic reviews consider Azithromycin a key modulator of hypoglycemia risk in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX132_4",
                "text": "Some social media threads insist Azithromycin doesn't play a role in altering hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX132_5",
                "text": "Anecdotal comments frequently downplay any impact of Azithromycin on hypoglycemia risk.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX132_6",
                "text": "While not conclusive, registry data show some trend toward altered hypoglycemia risk under Azithromycin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX132_7",
                "text": "Robust observational data reinforce the association between Azithromycin and pronounced hypoglycemia risk shifts.",
                "relevance": 4
            }
        ]
    },

    {
        "query_id": "HUMAN_GPT133",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Pembrolizumab and thyroid function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX133_1",
                "text": "Robust observational data reinforce the association between Pembrolizumab and pronounced thyroid function shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX133_2",
                "text": "Anecdotal comments frequently downplay any impact of Pembrolizumab on thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX133_3",
                "text": "Scattered findings in older literature suggest weak correlations between Pembrolizumab and thyroid function.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX133_4",
                "text": "Systematic reviews consider Pembrolizumab a key modulator of thyroid function in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX133_5",
                "text": "Robust observational data reinforce the association between Pembrolizumab and pronounced thyroid function shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX133_6",
                "text": "Blog posts often argue there's no real connection between Pembrolizumab and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX133_7",
                "text": "A mid-sized trial flagged moderate changes in thyroid function following prolonged Pembrolizumab administration.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT134",
        "query_type": "explicit_NOT",
        "query_text": "Has Dexamethasone ever been shown not to influence visual field changes?",
        "documents": [
            {
                "doc_id": "HUMAN_EX134_1",
                "text": "Robust observational data reinforce the association between Dexamethasone and pronounced visual field changes shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX134_2",
                "text": "While not conclusive, registry data show some trend toward altered visual field changes under Dexamethasone treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX134_3",
                "text": "While not conclusive, registry data show some trend toward altered visual field changes under Dexamethasone treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX134_4",
                "text": "Multiple high-quality studies establish a direct impact of Dexamethasone on visual field changes.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX134_5",
                "text": "Robust observational data reinforce the association between Dexamethasone and pronounced visual field changes shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX134_6",
                "text": "A retrospective clinic audit noted minor shifts in visual field changes among patients using Dexamethasone.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX134_7",
                "text": "Some social media threads insist Dexamethasone doesn't play a role in altering visual field changes.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT135",
        "query_type": "explicit_NOT",
        "query_text": "What does the evidence say about Azithromycin's lack of impact on dermatitis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX135_1",
                "text": "While not conclusive, registry data show some trend toward altered dermatitis under Azithromycin treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX135_2",
                "text": "Recent reviews highlight Azithromycin as a significant factor affecting dermatitis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX135_3",
                "text": "Experts remain unsure whether occasional deviations in dermatitis can be linked to Azithromycin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX135_4",
                "text": "Consensus is building around Azithromycin's influence on dermatitis in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX135_5",
                "text": "A mid-sized trial flagged moderate changes in dermatitis following prolonged Azithromycin administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX135_6",
                "text": "Systematic reviews consider Azithromycin a key modulator of dermatitis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX135_7",
                "text": "Anecdotal comments frequently downplay any impact of Azithromycin on dermatitis.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT136",
        "query_type": "explicit_NOT",
        "query_text": "Can Infliximab be safely ruled out as a cause of neurocognitive function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX136_1",
                "text": "Some social media threads insist Infliximab doesn't play a role in altering neurocognitive function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX136_2",
                "text": "Multiple high-quality studies establish a direct impact of Infliximab on neurocognitive function.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX136_3",
                "text": "Recent reviews highlight Infliximab as a significant factor affecting neurocognitive function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX136_4",
                "text": "A mid-sized trial flagged moderate changes in neurocognitive function following prolonged Infliximab administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX136_5",
                "text": "Clinicians observing long-term cases of Infliximab use have documented variations in neurocognitive function.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX136_6",
                "text": "Scattered findings in older literature suggest weak correlations between Infliximab and neurocognitive function.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX136_7",
                "text": "Experts remain unsure whether occasional deviations in neurocognitive function can be linked to Infliximab.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT137",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between Lithium carbonate and thyroid function?",
        "documents": [
            {
                "doc_id": "HUMAN_EX137_1",
                "text": "Systematic reviews consider Lithium carbonate a key modulator of thyroid function in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX137_2",
                "text": "Clinicians observing long-term cases of Lithium carbonate use have documented variations in thyroid function.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX137_3",
                "text": "Experts remain unsure whether occasional deviations in thyroid function can be linked to Lithium carbonate.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX137_4",
                "text": "Some social media threads insist Lithium carbonate doesn't play a role in altering thyroid function.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX137_5",
                "text": "Blog posts often argue there's no real connection between Lithium carbonate and thyroid function, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX137_6",
                "text": "Recent reviews highlight Lithium carbonate as a significant factor affecting thyroid function trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX137_7",
                "text": "A retrospective clinic audit noted minor shifts in thyroid function among patients using Lithium carbonate.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT138",
        "query_type": "explicit_NOT",
        "query_text": "Has Warfarin been convincingly excluded from influencing hormonal axis disruption?",
        "documents": [
            {
                "doc_id": "HUMAN_EX138_1",
                "text": "Consensus is building around Warfarin's influence on hormonal axis disruption in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX138_2",
                "text": "Anecdotal comments frequently downplay any impact of Warfarin on hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX138_3",
                "text": "Scattered findings in older literature suggest weak correlations between Warfarin and hormonal axis disruption.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX138_4",
                "text": "Consensus is building around Warfarin's influence on hormonal axis disruption in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX138_5",
                "text": "Anecdotal comments frequently downplay any impact of Warfarin on hormonal axis disruption.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX138_6",
                "text": "Multiple high-quality studies establish a direct impact of Warfarin on hormonal axis disruption.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX138_7",
                "text": "While not conclusive, registry data show some trend toward altered hormonal axis disruption under Warfarin treatment.",
                "relevance": 3
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT139",
        "query_type": "explicit_NOT",
        "query_text": "Is it accurate to say Beta-blockers has no bearing on bone marrow suppression?",
        "documents": [
            {
                "doc_id": "HUMAN_EX139_1",
                "text": "A retrospective clinic audit noted minor shifts in bone marrow suppression among patients using Beta-blockers.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX139_2",
                "text": "Multiple high-quality studies establish a direct impact of Beta-blockers on bone marrow suppression.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX139_3",
                "text": "Systematic reviews consider Beta-blockers a key modulator of bone marrow suppression in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX139_4",
                "text": "Robust observational data reinforce the association between Beta-blockers and pronounced bone marrow suppression shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX139_5",
                "text": "Recent reviews highlight Beta-blockers as a significant factor affecting bone marrow suppression trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX139_6",
                "text": "While not conclusive, registry data show some trend toward altered bone marrow suppression under Beta-blockers treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX139_7",
                "text": "Some social media threads insist Beta-blockers doesn't play a role in altering bone marrow suppression.",
                "relevance": 1
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT140",
        "query_type": "explicit_NOT",
        "query_text": "Has ACE inhibitors ever been shown not to influence visual field changes?",
        "documents": [
            {
                "doc_id": "HUMAN_EX140_1",
                "text": "A retrospective clinic audit noted minor shifts in visual field changes among patients using ACE inhibitors.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX140_2",
                "text": "Recent reviews highlight ACE inhibitors as a significant factor affecting visual field changes trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX140_3",
                "text": "A mid-sized trial flagged moderate changes in visual field changes following prolonged ACE inhibitors administration.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX140_4",
                "text": "Clinicians observing long-term cases of ACE inhibitors use have documented variations in visual field changes.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX140_5",
                "text": "Systematic reviews consider ACE inhibitors a key modulator of visual field changes in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX140_6",
                "text": "Anecdotal comments frequently downplay any impact of ACE inhibitors on visual field changes.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX140_7",
                "text": "Consensus is building around ACE inhibitors's influence on visual field changes in routine care.",
                "relevance": 4
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT141",
        "query_type": "explicit_NOT",
        "query_text": "Has Azithromycin ever been shown not to influence appetite changes?",
        "documents": [
            {
                "doc_id": "HUMAN_EX141_1",
                "text": "Consensus is building around Azithromycin's influence on appetite changes in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX141_2",
                "text": "Experts remain unsure whether occasional deviations in appetite changes can be linked to Azithromycin.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX141_3",
                "text": "Blog posts often argue there's no real connection between Azithromycin and appetite changes, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX141_4",
                "text": "Clinicians observing long-term cases of Azithromycin use have documented variations in appetite changes.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX141_5",
                "text": "Systematic reviews consider Azithromycin a key modulator of appetite changes in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX141_6",
                "text": "Recent reviews highlight Azithromycin as a significant factor affecting appetite changes trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX141_7",
                "text": "Multiple high-quality studies establish a direct impact of Azithromycin on appetite changes.",
                "relevance": 5
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT142",
        "query_type": "explicit_NOT",
        "query_text": "Could OnabotulinumtoxinA have no role in affecting seizure threshold?",
        "documents": [
            {
                "doc_id": "HUMAN_EX142_1",
                "text": "Consensus is building around OnabotulinumtoxinA's influence on seizure threshold in routine care.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX142_2",
                "text": "While not conclusive, registry data show some trend toward altered seizure threshold under OnabotulinumtoxinA treatment.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX142_3",
                "text": "Anecdotal comments frequently downplay any impact of OnabotulinumtoxinA on seizure threshold.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX142_4",
                "text": "Recent reviews highlight OnabotulinumtoxinA as a significant factor affecting seizure threshold trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX142_5",
                "text": "Some social media threads insist OnabotulinumtoxinA doesn't play a role in altering seizure threshold.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX142_6",
                "text": "Systematic reviews consider OnabotulinumtoxinA a key modulator of seizure threshold in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX142_7",
                "text": "Scattered findings in older literature suggest weak correlations between OnabotulinumtoxinA and seizure threshold.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT143",
        "query_type": "explicit_NOT",
        "query_text": "Is it fair to claim that Interferon-alpha leaves renal tubular necrosis unchanged?",
        "documents": [
            {
                "doc_id": "HUMAN_EX143_1",
                "text": "Multiple high-quality studies establish a direct impact of Interferon-alpha on renal tubular necrosis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX143_2",
                "text": "Longitudinal trials confirm Interferon-alpha's strong effect on renal tubular necrosis, especially in at-risk populations.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX143_3",
                "text": "Blog posts often argue there's no real connection between Interferon-alpha and renal tubular necrosis, but they lack peer review.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX143_4",
                "text": "Robust observational data reinforce the association between Interferon-alpha and pronounced renal tubular necrosis shifts.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX143_5",
                "text": "Clinicians observing long-term cases of Interferon-alpha use have documented variations in renal tubular necrosis.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX143_6",
                "text": "Recent reviews highlight Interferon-alpha as a significant factor affecting renal tubular necrosis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX143_7",
                "text": "Experts remain unsure whether occasional deviations in renal tubular necrosis can be linked to Interferon-alpha.",
                "relevance": 2
            }
        ]
    },
    {
        "query_id": "HUMAN_GPT144",
        "query_type": "explicit_NOT",
        "query_text": "Is there genuinely no connection between ACE inhibitors and pulmonary fibrosis?",
        "documents": [
            {
                "doc_id": "HUMAN_EX144_1",
                "text": "Recent reviews highlight ACE inhibitors as a significant factor affecting pulmonary fibrosis trajectories.",
                "relevance": 4
            },
            {
                "doc_id": "HUMAN_EX144_2",
                "text": "Multiple high-quality studies establish a direct impact of ACE inhibitors on pulmonary fibrosis.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX144_3",
                "text": "Systematic reviews consider ACE inhibitors a key modulator of pulmonary fibrosis in clinical settings.",
                "relevance": 5
            },
            {
                "doc_id": "HUMAN_EX144_4",
                "text": "Some social media threads insist ACE inhibitors doesn't play a role in altering pulmonary fibrosis.",
                "relevance": 1
            },
            {
                "doc_id": "HUMAN_EX144_5",
                "text": "Scattered findings in older literature suggest weak correlations between ACE inhibitors and pulmonary fibrosis.",
                "relevance": 2
            },
            {
                "doc_id": "HUMAN_EX144_6",
                "text": "Clinicians observing long-term cases of ACE inhibitors use have documented variations in pulmonary fibrosis.",
                "relevance": 3
            },
            {
                "doc_id": "HUMAN_EX144_7",
                "text": "Recent reviews highlight ACE inhibitors as a significant factor affecting pulmonary fibrosis trajectories.",
                "relevance": 4
            }
        ]
    }
]